21.03.2018 Views

March 2018

March 2018

March 2018

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

THE MAGAZINE FOR NEW ZEALAND’S OPHTHALMIC COMMUNITY<br />

PO BOX 106 954, AUCKLAND CITY 1143<br />

MARCH <strong>2018</strong><br />

Email: info@nzoptics.co.nz Website: www.nzoptics.co.nz


<strong>2018</strong> • Voted by New Zealanders • <strong>2018</strong><br />

TRANSFORMING<br />

EYE HEALTH<br />

THE ULTIMATE OPHTHALMIC COLLABORATION<br />

At Specsavers we are focussed on providing the highest<br />

levels of optometry and dispensing care in all our New<br />

Zealand and Australian stores.<br />

Our equipment and technology strategies, our close working relationships<br />

with ophthalmology and various eye disease stakeholders alongside our<br />

major investments into dispensing qualifications all contribute to a singular<br />

purpose – to transform the eye health of New Zealanders and Australians.<br />

So, if you’re concerned at the 50 per cent undiagnosed glaucoma cohort<br />

and the under-indexing of diabetic retinopathy screenings; if you’re worried<br />

that available in-store technology isn’t being used on every patient due to<br />

extra fees and charges; and if you’re alarmed at the under-investment in<br />

professional dispensing programs and technology – then we urge you to<br />

talk to us about how you can make a genuine impact at Specsavers.<br />

We’re on a clear mission to transform eye health in New Zealand and<br />

Australia – and we’d like you to join us on that mission.<br />

To ask about optometry and dispensing roles right across the country at all levels, contact Chris Rickard on 027 579 5499<br />

or chris.rickard@specsavers.com, alternatively visit spectrum-anz.com for all the opportunities.<br />

Reader’s<br />

Digest<br />

Quality Service<br />

Award<br />

<strong>2018</strong> • Voted by Australians • <strong>2018</strong><br />

Reader’s<br />

Digest<br />

Quality Service<br />

Award<br />

AITD<br />

Voted by New Zealanders<br />

Reader’s Digest<br />

Quality Service<br />

Award<br />

2017<br />

Best Customer<br />

Service in AU<br />

Optometry<br />

<strong>2018</strong><br />

Best Customer<br />

Service in NZ<br />

Optometry<br />

Best Talent<br />

Development<br />

Program<br />

2017<br />

Best Talent<br />

Development<br />

Program<br />

2017<br />

Best Customer<br />

Service in NZ<br />

Optometry<br />

2017<br />

Millward Brown<br />

Research<br />

No.1 for eye tests<br />

2016<br />

Excellence in<br />

Marketing<br />

Award<br />

2016<br />

Retail<br />

Store Design<br />

Award<br />

2016<br />

Retail<br />

Employer<br />

of the Year<br />

2015<br />

<strong>2018</strong> Transforming eye health<br />

2 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong>


DO textbook crisis?<br />

BY LESLEY SPRINGALL<br />

A<br />

change of mind at the last moment has<br />

saved budding New Zealand dispensing<br />

opticians from having to share textbooks<br />

this year, at least in the short-term.<br />

In January, the Open Training and Education<br />

Network (OTEN), part of TAFE NSW, decided to stop<br />

the supply of the Australasian dispensing optician<br />

(DO) course textbooks to rival DO course providers,<br />

including the Australasian College of Optical<br />

Dispensing (ACOD) which runs the accredited<br />

course in New Zealand.<br />

The course text books, Practical Optical<br />

Workshop by David Wilson, Steve Stenersen and<br />

Steven Daras, and Practical Optical Dispensing<br />

by David Wilson and Steven Daras, are relevant<br />

to the Australian/New Zealand context and are<br />

currently a key component of the ACOD course.<br />

ACOD’s course is endorsed by the Association of<br />

Dispensing Opticians in New Zealand (ADONZ)<br />

and NZ Optics understands OTEN’s decision to<br />

suddenly stop supplying the textbooks left little<br />

time to find alternatives and amend the course<br />

accordingly. Though OTEN retains the rights to the<br />

textbooks, the understanding was that the authors<br />

wanted them to always be available to all, said one<br />

source who didn’t wish to be named.<br />

The textbooks were written by the late David<br />

Wilson, who used to work for OTEN, was a cross-<br />

Tasman champion of the importance and skills<br />

of a good dispensing optician to any practice,<br />

and wanted Australasian DOs to have their own<br />

Australasian textbooks. Though other good<br />

textbooks exist in both the US and the UK, Wilson’s<br />

have become the standard in Australasia.<br />

The textbook stoush itself is believed to have<br />

been caused by the rise in the number of budding<br />

DOs now wishing to become qualified and, in New<br />

Zealand, registered, but who have chosen to seek<br />

alternative providers to OTEN, such as ACOD. ACOD<br />

was set up by former OTEN DO course teachers<br />

James Gibbins and Chedy Kalach, just over a year<br />

ago and reportedly enrolled more students in<br />

2017 than any other DO course provider after<br />

gaining the endorsement of ADONZ, Specsavers<br />

and Australian independent optometry group,<br />

ProVision, in late 2016 and early 2017.<br />

After being informed of OTEN’s decision to<br />

stop the supply and having no initial luck from<br />

negotiating with the New South Wales-based<br />

college, NZ Optics understands ACOD led an<br />

appeal together with<br />

some other industry<br />

associations, organisations<br />

and individuals to seek<br />

intervention from the<br />

NSW state government.<br />

Adding to ACOD’s appeal<br />

is a claim by Gibbins that<br />

the most recent editions of<br />

the textbooks were partly<br />

funded by an independent,<br />

private Optical Dispensing<br />

Education Fund (which has<br />

since closed) which adds<br />

to OTEN’s obligation to<br />

make the text books freely<br />

available to the wider<br />

industry. NSW Deputy Premier and Skills Minister,<br />

John Barilaro, and his Assistant Skills Minister<br />

Adam Marshall, are believed to be looking into the<br />

case.<br />

However shortly before going to press, OTEN<br />

had a change of heart and agreed to make the<br />

textbooks available to non-TAFE NSW students<br />

during the first half of <strong>2018</strong>. The decision was<br />

driven by OTEN’s consideration of the potential<br />

impact on students from other colleges which<br />

don’t have sufficient resources to develop<br />

materials for their students, said a spokesman for<br />

TAFE NSW.<br />

“However, in a competitive VET (vocational<br />

education and training) market, TAFE NSW does<br />

not consider that it is appropriate or reasonable,<br />

on an ongoing basis, to provide its resources to<br />

competitors in circumstances where TAFE NSW<br />

has invested significantly in its materials. TAFE<br />

NSW will be reviewing its textbooks in <strong>2018</strong> and<br />

is intending to update these resources for use in<br />

2019. TAFE NSW does not intend to provide these<br />

materials to third parties.”<br />

Given that the matter is currently still under<br />

ministerial review, ACOD directors’ Gibbins and<br />

Kalach were unable to comment in detail, however<br />

they did say they welcomed OTEN’s decision to<br />

re-supply the textbooks at least for the first half<br />

of <strong>2018</strong>. “Therefore, we expect to use the Wilson /<br />

Stenersen textbooks as usual for <strong>2018</strong>. According<br />

to our continuous improvement practise all ACOD<br />

learning materials, including the textbooks will be<br />

reviewed for 2019.”<br />

ADONZ president Donald Crichton said, “Going<br />

Steven Daras, one of the well-respected co-authors of the Australasian DO textbooks, at work at OTEN/TAFE<br />

forward I can see ACOD using different textbooks<br />

to complement their course delivery. I am<br />

confident that James and Chedy will manage a<br />

successful adaption and that future students will<br />

not be affected.”<br />

One of the textbooks co-author’s, New Zealandbased<br />

Steve Stenersen, a well-respected, longserving<br />

DO educator and champion in New<br />

Zealand who was recognised with an ADONZ life<br />

member award at the end of last year, however,<br />

said he was still very disappointed with OTEN’s<br />

decision. “OTEN have the legal right to block sales<br />

of the book. This is a moral issue. When I was asked<br />

by David to co-author the book with him it was<br />

with the intention that the book was available to<br />

all, including Australia, New Zealand as well as<br />

some sales in the UK, States and South Africa.”<br />

Stenersen said he would not support OTEN’s<br />

review of the textbooks if they continued to be just<br />

for OTEN’s use.<br />

In New Zealand in 2017, a record 54 students<br />

enrolled in ACOD’s certificate IV in optical<br />

dispensing course and larger numbers are<br />

expected for this year’s course. The flexible course<br />

is completed in 18-24 months part-time and<br />

includes online work as well as practical sessions<br />

at ACOD’s workshop in Glenfield, Auckland.<br />

Students are expected to have worked for at least<br />

a year in an optical practice before starting the<br />

course and then continue to work about 20 hours<br />

a week, while completing the course with the<br />

support of a workplace supervisor. ▀<br />

It’s about<br />

the patients<br />

EDITORIAL<br />

The many facets of the optical industry, from<br />

those who develop and sell the technology<br />

and resources eye health practitioners’ need<br />

to the optometry practice staff who assess our<br />

eye health and make us love our new specs to<br />

the ophthalmology team who help protect our<br />

precious sight, are all interconnected. So, it’s sad<br />

when one part lets down another as is the case in<br />

two stories this month.<br />

Admittedly, Australian dispensing optician<br />

(DO) training organisation TAFE NSW agreed<br />

not to suspend the sale of the Australasian<br />

DO textbooks at the last minute for this year’s<br />

student intake (this page), but didn’t DO-skills<br />

advocates and co-authors the late David Wilson,<br />

Steve Stenersen and Steven Daras write these<br />

textbooks to benefit the whole Australasian DO<br />

profession, without a time limit?<br />

Then there’s the NZ optometrist who didn’t<br />

pick up a six-year-old boy’s brain tumour and,<br />

worse, didn’t encourage the family to return if<br />

symptoms persisted (p4) or refer the child to<br />

someone who might have been able to spot<br />

something, just to be sure. We are all guilty of<br />

being tired and over confident at times and the<br />

resulting HDC report highlights the remorse<br />

of the now-retired optometrist, but this case<br />

couldn’t highlight more clearly the importance of<br />

this industry’s role.<br />

More positively, it’s great to hear Visique<br />

optoms getting the thumbs up from their<br />

patients (p4); the <strong>2018</strong> CCLS one-day conference<br />

(p8-13) should not be missed; the wonderful,<br />

entrepreneurial Kiwi ophthalmology registrar<br />

Hong opens our eyes to the power of AI (p14);<br />

and we take a look at safety (p14, 18) and today’s<br />

retail trends (p19),<br />

plus much, much<br />

more. Enjoy!<br />

Lesley Springall, editor, NZ Optics<br />

ODOB reviews TAFE DO<br />

course<br />

The optometrists and<br />

dispensing opticians<br />

board (ODOB) is currently<br />

consulting on the revocation<br />

of the accreditation of the<br />

‘Certificate IV in Optical<br />

Dispensing’ course offered<br />

by OTEN/TAFE in New South<br />

Wales after OTEN failed to<br />

provide additional material<br />

requested for its accreditation.<br />

If the accreditation is revoked,<br />

dispensing opticians (DOs)<br />

trained at OTEN will no longer<br />

be recognised for registration in New Zealand.<br />

In New Zealand, the ODOB is charged under<br />

the Health Practitioners Competence Assurance<br />

Act 2003 to ensure DOs are competent and fit to<br />

practise when they apply for registration, which<br />

requires the ODOB to prescribe the qualifications<br />

required to meet the current scopes of practice.<br />

The ODOB first prescribed the dispensing course<br />

offered by OTEN as a qualification for optical<br />

dispensing in 2005. In October 2014, the ODOB<br />

asked OTEN for its reaccreditation application, but<br />

OTEN advised that its course was under review,<br />

so the ODOB placed its reaccreditation on hold.<br />

In June 2016, OTEN provided its reaccreditation<br />

application and when asked for additional<br />

information, NZ Optics’ understands OTEN again<br />

asked for the reaccreditation to be placed on hold<br />

due to an impending governance restructure. As<br />

this was the second request and reaccreditation<br />

was well overdue, the ODOB declined and gave<br />

OTEN a deadline of 14 July 2017, which it failed<br />

to meet.<br />

“The course might well still be suitable for<br />

dispensing in New Zealand but OTEN have had<br />

more than enough time to satisfy the board of this<br />

by providing documentation and have failed to do<br />

The ODOB is considering revoking OTEN’s accreditation for its DOs in NZ<br />

so – hence the consultation on revocation of their<br />

accreditation,” said Lindsey Pine, ODOB registrar.<br />

“The board will consider submissions once the<br />

consultation closes and make a final decision.<br />

If the course is revoked, notice will officially be<br />

published in the New Zealand Gazette.<br />

“OTEN were advised some time ago that<br />

they needed to let these students know the<br />

Board’s decision to propose revocation of the<br />

qualification.”<br />

Donald Crichton, president of the Association<br />

of Dispensing Opticians of New Zealand (ADONZ)<br />

said, “This will not affect currently registered<br />

dispensing opticians who studied with OTEN, only<br />

those choosing to embark on the OTEN course<br />

from <strong>2018</strong>. There are no New Zealand students<br />

currently studying through OTEN. Students<br />

can train through the Australasian College of<br />

Dispensing (ACOD) with the support of OptiBlocks.<br />

There are currently more than 50 students enrolled<br />

in this course, many of any of whom will be ready<br />

to join the register as dispensing opticians by the<br />

end of this year.”<br />

When contacted, a spokesman for TAFE NSW said<br />

the college was reapplying for reaccreditation and<br />

was currently midway through the process. ▀<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

3


News<br />

in brief<br />

CL SOLUTION SAVES BIRD<br />

Japanese contact lens (CL) company<br />

Menicon has come to the aid of rice<br />

paddy farmers on Sado Island who are<br />

trying to save the local Japanese crested<br />

Ibis. Rice farmers are encouraged to<br />

leave their paddies submerged during winter to enable the birds to<br />

continue to feed, but that left the farmers unable to clear leftover rice<br />

straw, which interferes with rice cultivation. Menicon used its stain<br />

removal CL solution technology knowhow to produce a dry form of its<br />

solution to sprinkle on the rice fields to accelerate decomposition. The<br />

ibis had been near extinction, but is now growing in numbers.<br />

NON-URGENT HOSPITAL VISITS FALL IN AUSTRALIA<br />

Almost 120,000 people presented for eye conditions at emergency<br />

departments across Australia in 2016-17, of which 19,640 were<br />

considered non-urgent. While the number of people seeking help<br />

from emergency departments for eye health issues is still a concern,<br />

said industry body Optometry Australia, it is encouraged by a<br />

noticeable 25% drop in non-urgent conditions over the last three<br />

years, which could relate to people’s better understanding of an<br />

optometrist’s role.<br />

GOGGLES FOR GLAUCOMA<br />

A new portable brain-computer interface,<br />

nGoggle, is proving promising for assessing<br />

visual function loss in glaucoma patients, said<br />

co-inventor Professor Felipe Medeiros from Duke<br />

University, North Carolina. In initial testing,<br />

nGoggle demonstrated greater accuracy compared with standard<br />

automated perimetry for discriminating eyes with glaucomatous<br />

optic neuropathy versus healthy eyes, he told Ophthalmology Times.<br />

PROF SHRINKS RETINA SCANNER<br />

Professor Marinko Sarunic from Simon Fraser University, Canada has<br />

developed a new, shoebox-sized, retinal imaging scanner, that can still<br />

produce high-resolution, 3D, cross-sectional retina images, showing<br />

individual photoreceptors, fine capillaries and blood vessels. It’s<br />

unique small size makes it perfectly suited for everyday use in medical<br />

clinics and hospitals, he said.<br />

DIOR OPENS EYEWEAR STORE<br />

Luxury fashion house Dior has opened its first store dedicated to<br />

eyewear. Located on Avenue Montaigne in Paris, next to its historic<br />

flagship premises, the store offers Dior sunglasses and optical frames,<br />

including exclusive designs and vintage pieces, optical accessories and<br />

makeup. Optometrists will provide vision screening in store.<br />

FIRST PATIENT RECEIVES PRIMA IMPLANT<br />

French company Pixium Vision has successfully completed its first<br />

human implantation and activation of Prima, its miniaturised,<br />

wireless photovoltaic sub-retinal implant, in a patient with severe<br />

vision loss from atrophic dry age-related macular degeneration<br />

(AMD). “Following activation, the patient reported a first perception<br />

of light from the central zone where there was none previously,”<br />

said Dr Yannick Le Mer, principal investigator for Prima’s first human<br />

feasibility study. “The patient now proceeds to the important reeducation<br />

phase to learn to interpret the light signals and evaluate<br />

the performance of the system.”<br />

RAINDROP MANUFACTURER CLOSES DOWN<br />

Revision Optics, manufacturer of the Raindrop implantable corneal<br />

device for correction of near vision, the first FDA-approved device<br />

that changes the shape of the cornea to correct vision, has closed<br />

down. Though it said it still hopes to still sell the IP for Raindrop,<br />

currently it has no offers. Raindrop received FDA approval in<br />

June 2016 and Revision raised US$32 million, led by Johnson &<br />

Johnson Development, in November 2016 to support Raindrop’s<br />

commercialisation.<br />

CHARITIES FOR VISION MERGE<br />

Optometry Giving Sight is to merge with the Brien Holden Vision<br />

Institute (BHVI) Foundation. “By merging our operations, we become<br />

more effective and gain the opportunity to maximise the resources<br />

that we can dedicate to key programme areas,” said Professor Kovin<br />

Naidoo, BHVI’s CEO.<br />

NEW DOCUMENTARY ON MYOPIA<br />

US filmmaker Jane Weiner is working on a<br />

documentary about myopia entitled ‘Losing Sight’,<br />

scheduled for release in 2020. Having done several<br />

films on health issues, Weiner said she was inspired<br />

when she heard about the current epidemic.<br />

“Everyone in my family is near-sighted, and although<br />

we’ve had our share of eye problems (cataracts, retinal detachment,<br />

macular degeneration, glaucoma), no one ever mentioned these<br />

maladies might be linked to our myopia.” A trailer is available at<br />

https://vimeo.com/215833148<br />

CAPITALISING ON THE GLOBAL GLAUCOMA MARKET<br />

Driven by the launch of new products, the total glaucoma market is<br />

expected to grow to US$3.8bn in 2026 from US$2.6bn in 2016, giving<br />

the market a compound annual growth rate of 4.1%, reported market<br />

intelligence company GlobalData. New products due for release<br />

include Santen’s DE-117, Aerie’s fixed-dose combination therapy,<br />

Roclatan, and two sustained-release implants.<br />

NZ optometrist censured<br />

A<br />

New<br />

Zealand optometrist has been<br />

found guilty of breaching the Code<br />

of Health and Disability Services<br />

Consumers’ Rights for not providing an<br />

adequate level of care and skill for a sixyear-old<br />

boy, later diagnosed with a brain<br />

tumour which left him blind in one eye and<br />

partially sighted in the other.<br />

In a report released in February, and<br />

covered widely by the general media, deputy<br />

health and disability commissioner (HDC)<br />

Meenal Duggal also found the optometrist’s<br />

practice liable for his inadequate care and<br />

recommended current directors take several<br />

steps to better care for their patients.<br />

All parties were unnamed in the report, but the optometrist was<br />

a director of the practice when he first examined the boy during an<br />

appointment on 28 <strong>March</strong> 2014. The visit was recorded as routine,<br />

but no details of the boy’s symptoms, family ocular history, general<br />

health or medications were documented. The optometrist recorded<br />

the boy’s visual acuity in his left eye as 6/10 and right as 6/x,<br />

meaning the boy could not identify the letters on the Snellen chart.<br />

The optometrist diagnosed amblyopia, possible right eye exotropia,<br />

and prescribed the boy glasses. No plan for follow-up or further<br />

investigation was noted. The HDC’s report also says the optometrist<br />

did not refer the boy for further testing or perform appropriate<br />

diagnostic tests to rule out pathology.<br />

A year later, the boy was taken by his parents to a medical centre,<br />

suffering headaches, fever and vomiting. The first GP he saw diagnosed<br />

tonsillitis and dehydration, but made a plan in case the boy’s condition<br />

deteriorated. The boy was taken back to the medical centre a week<br />

later, suffering severe headaches. He also couldn’t walk straight, had<br />

started rubbing and banging his head, couldn’t see and was barely<br />

talking. He was seen by a different GP who sent him to hospital for<br />

a CT-scan which identified a craniopharyngioma brain tumour. The<br />

tumour was removed and the boy survived, but he was left completely<br />

blind in his right eye and had just 1/30 acuity in his left.<br />

Duggal said the optometrist failed to take appropriate steps to<br />

test the level of acuity of the boy’s right eye, consider differential<br />

diagnoses, conduct further investigations or refer the boy to an<br />

ophthalmologist to determine the cause of the amblyopia and<br />

queried exotropia. He also failed to put together an ongoing<br />

VOSO to tackle low vision<br />

The Volunteer Ophthalmic Services Overseas<br />

(VOSO) eye health aid group is adding low<br />

vision to its list of aid services from this year<br />

and is urgently seeking donations of low vision<br />

equipment to distribute in the Pacific Islands to low<br />

vision patients.<br />

Auckland-based low vision consultant and<br />

optometrist Naomi Meltzer has volunteered her<br />

services to VOSO and, in collaboration with the Blind<br />

Foundation, will provide low vision aids such as<br />

magnifiers, high plus spectacles and sunglasses and<br />

other small low vision aids, which are currently being<br />

collected by Blind Foundations centres throughout<br />

New Zealand.<br />

VOSO is a New Zealand charitable trust that<br />

provides free eye care to the people of the Pacific.<br />

This completely voluntary-based organisation was<br />

established 30 years ago and visits Fiji, Samoa and<br />

Tonga on an annual basis to help restore vision<br />

through sight-saving cataract surgery and refractive<br />

services, including supplying thousands of pairs of glasses each year.<br />

Two-thirds of the world’s population with low vision resides in the<br />

Asia-Pacific region 1 . Providing low vision aids is important for improving<br />

patient quality of life, however there are many issues and challenges for<br />

the provision of low vision aids in the pacific, said Meltzer.<br />

“There is huge difficulty getting low vision services in many third<br />

world countries. New Zealand has a lot more resources than our Pacific<br />

Island neighbours and so there are many magnifiers and low vision<br />

aids, which are no longer required, sitting in the backs of drawers in<br />

homes around the country.”<br />

Meltzer said her offer to add low vision aids and training to the next<br />

VOSO trip was met with an enthusiastic and emotional response.<br />

“This is history in the making,” said Shireen Ali from the New Zealand<br />

Blind Foundation.<br />

Meltzer will be accompanying the VOSO team on their next trip in July<br />

to Labasa, Fiji. Labasa has a high rate of diabetic retinopathy and one of<br />

the highest rates of albinism in the world.<br />

www.nzoptics.co.nz | PO Box 106954, Auckland 1143 | New Zealand<br />

treatment plan to see if the boy’s visual<br />

acuity improved or appropriately document<br />

the boy’s history and reason for coming to<br />

see the optometrist in the first place.<br />

The censured optometrist retired from<br />

clinical practice in 2015, but is still involved<br />

in the management of the optometry<br />

practice. He’s asked to be removed from<br />

the Optometrist and Dispensing Opticians<br />

Board (ODOB) register and is currently noted<br />

on the register as non-practising. In his<br />

response to the HDC, he said in <strong>March</strong> 2014<br />

he was experiencing stress and anxiety due<br />

The HDC has criticised an NZ optometrist for his lack of care to personal matters and had, had difficulty<br />

obtaining locum optometrist cover. He said<br />

he had “contemplated and agonised” over the probable cause of<br />

the misdiagnosis of the boy’s eyesight and is “profoundly regretful”.<br />

On Duggal’s recommendation, he also said he “wishes to apologise<br />

profusely both to (the boy) and his parents for what has happened”.<br />

Despite the optometrist telling the HDC he is no longer practising,<br />

Duggal recommended the ODOB provide an update on his<br />

registration status within three months of the report and, should<br />

he decide to return to clinical practice, asked the Board to consider<br />

whether a review of his competence is warranted.<br />

The practice was found vicariously liable for the optometrist’s<br />

breach of code and censured for failing to have policies or procedures<br />

in place relating to staffing levels when unexpected leave was<br />

required and the standard of the consultation form used at the<br />

time. The practice was told to discuss the findings of the report with<br />

its clinical staff; review its consultation form and recall processes;<br />

and audit patient records for a one-month period to ensure that<br />

patients assessed have been appropriately referred. It was also asked<br />

to provide an update on the changes it has made to its practice,<br />

including the implementation of its new policies and procedures,<br />

and to conduct a second audit and report back to the HDC on the<br />

effectiveness of these changes to ensure patients have been referred<br />

appropriately.<br />

A copy of the report and the optometrist’s name has been sent<br />

to the ODOB, the New Zealand Association of Optometrists, the<br />

Corneal and Contact Lens Society, ACC and the district health<br />

board. To read the full report, go to http://www.hdc.org.nz/<br />

media/390312/16hdc00646.pdf. ▀<br />

VOSO wants your old low vision aids for its new Pacific low vision initiative<br />

“I am feeling very excited about the VOSO trip, and also a little<br />

nervous,” she said. “This is my first VOSO trip and I am expecting it to be<br />

hard work and an amazing experience. I am learning a lot from people<br />

who have been involved in VOSO, but the low vision part is adding<br />

another dimension and is rather an unknown. We will definitely need<br />

lots of sunglasses and low vision aids (in Lambasa) so I am hoping to<br />

encourage optometrists and ophthalmologists to put the word out.”<br />

If you have any small low vision aids (not CCTV devices) that you would<br />

like to donate, please send these to Naomi Meltzer, Low Vision Services,<br />

PO Box 28486, Remuera, Auckland 1541, or drop them in at a Blind<br />

Foundation centre in New Zealand.<br />

For more about VOSO, visit www.voso.org.nz<br />

References:<br />

1. Chiang PP et al. Critical issues in implementing low vision care in the Asia-<br />

Pacific region. Indian J Ophthalmol. 2012 Sep-Oct;60(5):456-9.<br />

For general enquiries or classifieds please email info@nzoptics.co.nz<br />

For editorial, please contact Lesley Springall at lesley@nzoptics.co.nz or +64 27 445 3543<br />

For all advertising/marketing enquiries, please contact Susanne Bradley at susanne@nzoptics.co.nz or +64 27 545 4357 in the first instance, or Lesley Springall at lesley@nzoptics.co.nz<br />

To submit artwork, or to query a graphic, please email susanne@nzoptics.co.nz<br />

NZ Optics magazine is the industry publication for New Zealand’s ophthalmic community. It is published monthly, 11 times a year, by New Zealand Optics 2015 Ltd. Copyright is held by<br />

NZ Optics 2015 Ltd. As well as the magazine and the website, NZ Optics publishes the annual New Zealand Optical Information Guide (OIG), a comprehensive listing guide that profiles the<br />

products and services of the industry. NZ Optics is an independent publication and has no affiliation with any organisations. The views expressed in this publication are not necessarily<br />

those of NZ Optics 2015 Ltd or the editorial team.<br />

4 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong>


Don’t get mad at<br />

corporate optometry.<br />

Get even.<br />

MyHealth1st gives independent optometrists the competitive edge<br />

with our revolutionary digital customer engagement platform<br />

Smarter, more convenient recalls<br />

for optometrists and customers<br />

The No.1 online bookings platform<br />

for independent optometrists<br />

Learn more about your customers while<br />

increasing post-consultation sales<br />

Join the digital revolution<br />

myhealth1st.co.nz/optometry<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

5


Shamir opens new Kiwi lab<br />

Shamir has opened a new fitting lab and<br />

service centre near Sylvia Park shopping<br />

precinct in the Mt Wellington area in<br />

Auckland.<br />

Shamir’s business in New Zealand is steadily<br />

growing and having a local presence is a priority<br />

for Shamir, on a global scale, says Tony Egerton,<br />

Shamir’s national sales manager. “To do this<br />

efficiently, with recommendations from our<br />

existing client base, our next step was to open<br />

a local lab and customer service outlet. With<br />

this we can now provide even better service and<br />

quicker turnaround times than those already<br />

currently enjoyed by our clients all over New<br />

Zealand.”<br />

The new lab’s location is ideal for Shamir and<br />

our New Zealand customers, adds Egerton. “It<br />

offers easy access to motorways and the airport,<br />

as well as being only 10km from Auckland’s CBD,<br />

all of which is important to be able to provide<br />

first rate service and fast delivery times to<br />

our New Zealand customers. By having a local<br />

Shamir’s NZ team Veronica Petersen and Francois Cronje<br />

office, we can centralise all ordering and logistic<br />

services; including phone, email, fax and online<br />

ordering systems. Same day fitting will also be<br />

available.”<br />

Shamir’s goal is to become the number one<br />

local lens supplier in the New Zealand market,<br />

says Egerton, and it’s hoping to achieve this by<br />

providing great service, professional advice and<br />

unique products offering a point of difference for<br />

independent practitioners.<br />

Joining Shamir’s New Zealand account and sales<br />

manager, Francois Cronje, at the new Aucklandbased<br />

lab, is Veronica Petersen, who previously<br />

worked with Cronje at Gary Filer Optometrist’s.<br />

Petersen will be managing the office and<br />

supporting customers, says Cronje, adding he’s<br />

proud of their combined 34 years in the optical<br />

industry. “I believe Veronica and I are uniquely<br />

qualified to handle the specific demands of<br />

the optometric industry in New Zealand. Both<br />

of us are registered dispensing opticians and<br />

skilled spectacle technicians with many years<br />

of fitting experience. We are confident we bring<br />

a skillset to Shamir New Zealand ensuring very<br />

high standards of expertise, product knowledge<br />

and excellent customer service to every Shamir<br />

client.” ▀<br />

Visique tops for customer satisfaction<br />

Jose George, Canstar general manager, presenting IOG’s Neil Human with the group’s Canstar Award for<br />

customer satisfaction<br />

Visique has won this year’s Canstar Blue Award for customer<br />

satisfaction in the New Zealand optometrists’ category.<br />

As Visique practices are part a cooperative of independent<br />

optometrists, now called The Independent Optometry Group (see<br />

February’s NZ Optics), not a chain, they are extremely proud of this result,<br />

said Neil Human, chief executive of The Independent Optometry Group.<br />

“This is a fantastic result and a strong endorsement of our practice<br />

owners and their staff and the attention that they pay to servicing<br />

their customers’ needs – the very reason we are now this year’s award<br />

winners.” It also shows how Visique’s practice owners are succeeding in<br />

what is a very competitive market, he added.<br />

Launched in June 2011, Canstar Blue is a customer satisfaction<br />

research and ratings business set up to help consumers make better<br />

purchasing decisions. In New Zealand it surveyed 2,500 New Zealand<br />

consumers across a range of categories to measure and track customer<br />

satisfaction. The outcomes reported are the results from customers who<br />

have used a national chain of optometrists within the last three years –<br />

in this case, 1,262 New Zealanders. Visique scored a maximum five stars<br />

in every category, beating Specsavers and OPSM which were second and<br />

third respectively. ▀<br />

ESA expands<br />

Drs Monika Pradhan and Hussain Patel in the new Manukau clinic<br />

Eye Surgery Associates (ESA) has expanded its<br />

operations in Auckland with a new location in<br />

Manukau joining its two existing clinics on the<br />

North Shore and in central Auckland.<br />

“Our new Manukau location will provide greater<br />

convenience for our South Auckland patients<br />

and referrers,” said Eye Surgery Associates<br />

ophthalmologist Dr Hussain Patel. Another driver<br />

was more space and more clinic time for Dr Monika<br />

Pradhan, who recently joined the practice, said Dr<br />

Patel, adding that both himself and Dr Pradhan will<br />

be working across all three clinics.<br />

“Our overall goal is to provide improved coverage and<br />

access to our ophthalmic services for a wider range<br />

of patients and referrers within the Auckland region.”<br />

Eye Surgery Associates is also looking to add one<br />

more ophthalmologist to the team to complement Dr<br />

Patel’s and Dr Pradhan’s specialist knowledge in retina,<br />

glaucoma and cataract surgery.<br />

The new Manukau operation opened in December<br />

last year and is fully equipped with the latest<br />

technologies including OCT imaging, visual field<br />

analysers, corneal topography, optic disc and retinal<br />

photography and lasers including YAG, SLT and retinal<br />

and intravitreal injections, said Dr Patel. ▀<br />

Education Series <strong>2018</strong><br />

Theme - Diagnostics and Therapeutics in Everyday Practice<br />

Seminars<br />

are FREE!<br />

Upcoming Seminar<br />

Tuesday<br />

22nd May<br />

6.30pm - 8.45pm<br />

Ellerslie Event Centre<br />

Racecourse, 80 Ascot Ave<br />

Ellerslie, Auckland<br />

5.45pm - 6.30pm<br />

Light Meal & Beverages<br />

provided<br />

Eye Institute’s Education Series continues to<br />

offer an opportunity for the Optometry Profession<br />

to gain exposure to the latest advances in<br />

therapeutics, shared-care management and<br />

surgical advances in New Zealand. You are invited<br />

to join us at our May and August Seminars and<br />

November Conferences for the <strong>2018</strong> year.<br />

BOOK ONLINE NOW!<br />

https://www.eyeinstitute.co.nz/optometry/<br />

August Seminar<br />

Tuesday<br />

16 Aug <strong>2018</strong><br />

6.30pm-8.45pm<br />

Ellerslie Event Centre<br />

Racecourse, 80 Ascot Ave<br />

Ellerslie, Auckland<br />

Optometry<br />

Conference<br />

Sunday<br />

4 Nov <strong>2018</strong><br />

8am-5pm<br />

Waipuna Conference Centre<br />

Mt Wellington, Auckland<br />

Dispensing Optician<br />

Conference<br />

Sunday<br />

4 Nov <strong>2018</strong><br />

8am-5pm<br />

Waipuna Conference Centre<br />

Mt Wellington, Auckland<br />

PLUS 1/2 Day<br />

Workshops<br />

Saturday<br />

3 Nov <strong>2018</strong><br />

1-5pm<br />

Waipuna Conference Centre<br />

Mt Wellington, Auckland<br />

Qualifies for <strong>2018</strong><br />

CPD Credits (including<br />

Therapeutics)<br />

BOOK ONLINE<br />

NOW<br />

Or register by<br />

Phone 09 522 2125<br />

Fax 09 522 5770<br />

conference@eyeinstitute.co.nz<br />

6 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong>


Progressive Lens Brand Winner<br />

Shamir<br />

Autograph III<br />

A New Visual Experience<br />

• Individually designed progressive lens to suit<br />

the patients prescription and frame choice<br />

• Incorporates Shamir Eye-point Technology III<br />

for a clear view of the world as it really is<br />

• New and improved intermediate vision when<br />

viewing digital devices<br />

• Ensures a clear and comfortable visual experience<br />

www.shamir.co.nz<br />

Phone 0800 SHAMIR<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

7


SPECIAL FEATURE: CCLS <strong>2018</strong><br />

CCLS <strong>2018</strong>: one special day<br />

BY SUSANNE BRADLEY<br />

<strong>March</strong> is here, which means it’s time for the Cornea and<br />

Contact Lens Society (CCLS) of New Zealand’s annual<br />

conference. This year, the shorter, one-day format is back,<br />

with the event scheduled for Sunday 18 <strong>March</strong> at Mac’s Brewbar and<br />

Function Centre on Wellington’s waterfront, just a few steps from Te<br />

Papa.<br />

Jagrut Lallu, CCLS’ new president who will be MC for the day, says<br />

the biennial return to Wellington for the CCLS one-day conference<br />

was welcomed by members.<br />

“Great support from attendees<br />

and sponsors alike shows this is<br />

the right location. This year, we<br />

again have excellent speakers<br />

together with an interesting and<br />

informative programme that<br />

will hopefully help ensure high<br />

attendance rates once again.”<br />

CCLS NZ president, Jagrut Lallu<br />

The programme<br />

DRY EYE<br />

DV891-0817<br />

The <strong>2018</strong> conference<br />

programme includes short<br />

talks (20-30 minutes) from nine<br />

invited speakers from CCLS New<br />

Zealand’s member optometrists<br />

and ophthalmologists as well as<br />

one overseas guest. The keynote<br />

EYE-LIGHT®<br />

The solution for meibomian gland dysfunction<br />

OPE ® /IPL + Light Modulation ® /LLLT<br />

• No GEL, no mess, streamlined treatment times<br />

• Lower ongoing and consumable costs<br />

• Improved safety margins with OPE ® technology<br />

- no contact surfaces and no risk of gel burns<br />

• IPL for treatment of the Lower Lid<br />

• LLLT for direct treatment of the Upper lid and face<br />

• Skin Type detected automatically, no guess work using a grading card<br />

0800 338 800 Mobile: 021 990 200<br />

designsforvision.co.nz Email: Ralph.Thompson@dfv.com.au<br />

View from the conference centre balcony at Mac’s Brewbar in Wellington<br />

• Pulse intensity is controlled automatically, but can be overridden by experienced operator<br />

Both technologies are certified with FDA and CE Medical Certification.<br />

DRY EYE<br />

Blephasteam<br />

Therapeutic heat and moisture<br />

treatment for the relief of<br />

Meibomian Gland Dysfunction<br />

and associated diseases.<br />

speakers are our own Professor Charles McGhee and Associate<br />

Professor Jennifer Craig.<br />

Professor McGhee, is chair of ophthalmology and head of the<br />

Department of Ophthalmology at the University of Auckland. He’s<br />

co-authored more than 300 scientific papers and is internationally<br />

recognised within the field of corneal diseases. A consultant<br />

ophthalmologist for 25 years, he has performed more than 1000<br />

TREATMENT<br />

ANALYSIS<br />

See the EYE-LIGHT and<br />

Keratograph 5M at CCLS<br />

Wellington Sunday 18 <strong>March</strong> <strong>2018</strong><br />

MASTROTA D.E.R.M. Punctal Plugs<br />

Paddle Forceps Roller<br />

Forceps<br />

OCULUS<br />

Diagnostic Dry Eye Assessment<br />

Meibo-scan<br />

• Infra Red LED<br />

Imaging<br />

• Blue & White LED<br />

Tranquileyes<br />

OCULUS KERATOGRAPH 5M<br />

TF-Scan<br />

• White LED<br />

TF-Scan, R-scan<br />

• White or IR Placido-ring<br />

Optimel / Optimel Manuka Plus<br />

Topography<br />

Antibacterial Honey Eye Drops for<br />

improved ocular surface health and<br />

reduced inflammation. Available in a<br />

16% honey drop and 98% honey gel.<br />

corneal transplants and has pioneered a number of techniques<br />

including corneal stem cell transplants, and he has a longstanding<br />

sub-specialty interest in cataract surgery and reconstruction of the<br />

anterior segment of the eye following trauma. Professor McGhee<br />

is giving three lectures at this year’s CCLS conference, covering the<br />

assessment and treatment of the anterior segment; complex cornea<br />

and anterior segment clinical cases; and keratoconus – the neverending<br />

story. To find out more about how Professor McGhee got<br />

into eye health, see NZ Optics’ <strong>March</strong> issue, last year.<br />

A/Prof Jennifer Craig is head of the ocular surface laboratory at<br />

the University of Auckland and vice chair of the Tear Film & Ocular<br />

Surface Society’s (TFOS’s) second international workshop (DEWS II)<br />

who’s work and research into dry eye is recognised internationally.<br />

At this year’s event, she will share the key learnings from DEWS II<br />

and their impact on dry eye diagnosis and management; explore<br />

the predisposition of the Asian eye to dry eye disease; and discuss<br />

how Manuka honey could help with blepharitis management. For<br />

more about A/Prof Craig’s talk and how she began her journey in<br />

eye health see p10.<br />

During the morning, CCLS <strong>2018</strong> attendees will also hear from<br />

Dr Ilva Rupenthal, head of the Buchanan Ocular Therapeutics<br />

Unit at the University of Auckland, on semi-fluorinated alkanes;<br />

and optometrists William Shew, who will discuss new insights on<br />

meibomian cyst interventions, and Alex Petty who will share some<br />

of his more complicated and fascinating cornea and contact lens<br />

(CL) cases. In the lead up to lunch, Tony Alexander, chief economist<br />

at the BNZ, will again impart some of his economic wisdom after<br />

being re-invited to speak following rave reviews from members<br />

who attended his talk in 2016.<br />

After lunch, Kiwi ophthalmologist Dr Dean Corbett will share<br />

his knowledge on extended depth of focus intraocular lenses for<br />

use in post-radial keratotomy corneas; optometrist Emilie Langley<br />

will tackle orthokeratology regression; Canadian guest speaker<br />

Professor Heather Sheardown, chair in ophthalmic biomaterials at<br />

the Department of Chemical Engineering of McMaster University<br />

in Ontario will discuss surface modification of contact lenses (CLs)<br />

for improved properties; and optometrist Alan Saks will present a<br />

talk entitled Life, the universe and CLs.<br />

The workshop is back<br />

The inaugural CCLS one-day conference workshop was<br />

oversubscribed in 2016 so it’s back this year, focusing on optical<br />

coherence tomography (OCT). CCLS councillor and Hamilton-based<br />

ophthalmologist Dr Chris Murphy is running the workshop which<br />

will provide an overview of the uses and limitations of OCT in<br />

glaucoma, medical retina and the anterior segment. For more, see<br />

Dr Murphy’s overview on p10.<br />

And a pub quiz<br />

On the social side, new president Lallu says the committee wanted<br />

to try something new. “Feedback received told us attendees<br />

wanted an all-inclusive event as part of the registration fee.” So,<br />

this year CCLS is offering an all-inclusive opportunity to connect<br />

and network prior to the conference through a pub quiz and<br />

crawl on the Saturday night for attendees and partners. The quiz<br />

and crawl is organised by some of CCLS’s local Wellington council<br />

members, just in time for St Patrick’s day. Don’t forget to sign up to<br />

the quiz, included in the conference fee,when registering.<br />

The details<br />

The OTC workshop is an optional addition to the conference and<br />

will be held at The Meeting Space, Level 2, 148 Cuba St (entrance<br />

off Garrett St) on Saturday 17 <strong>March</strong> from 9am to 4pm. The<br />

workshop has been awarded 5.67 CD and 0.33 general credits.<br />

Again, spaces are limited, so delegates need to book in advance if<br />

they want to go.<br />

For the conference proper, registration opens at 7.30am on<br />

Sunday 18 <strong>March</strong>. Breakfast will be served from 8am with the<br />

president’s welcome at 8.30am. Lectures begin at 8.30am, lunch at<br />

12.20pm followed by the AGM at 1.20pm with lectures resuming<br />

at 2pm. The educational part of the day finishes at 5pm with a<br />

well-earned cocktail function at Mac’s!<br />

The CCLS Conference has been awarded 1.486 CD and 4.126<br />

general credits. For more information and to register, visit:<br />

http://www.contactlens.org.nz/ccls-1-day-conference-18thmarch-<strong>2018</strong>/<br />

As always NZ Optics will be supporting the event, so we look<br />

forward to seeing you there.<br />

CONTINUED ON PAGE 10<br />

8 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong>


6<br />

months<br />

shelf life after<br />

opening<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

9


SPECIAL FEATURE: CCLS <strong>2018</strong><br />

CCLS <strong>2018</strong>: OCT workshop<br />

BY DR CHRIS MURPHY*<br />

The optical coherence tomography (OCT)<br />

workshop will give an overview of the main<br />

areas when OCT is useful in optometry<br />

practice. It will help optometrists to become more<br />

confident in diagnosis and differentiating pathology<br />

from the normal range and offer suggestions on if,<br />

when and how quickly to refer.<br />

The first session starts with an overview of the<br />

fundamentals of OCT technology, including the<br />

advantages of swept-source OCT.<br />

Dr Jesse Gale will then provide a review of<br />

the role of OCT in glaucoma diagnosis and<br />

management. There is debate about the role<br />

of glaucoma imaging tests in the community<br />

optometry setting. For example, by scanning<br />

all customers will we successfully screen for<br />

glaucoma and prevent blindness or will we<br />

generate a tsunami of ‘worried well’ with yellow<br />

and red segments on their print-outs? These<br />

Evolve ® Hypromellose 0.3%<br />

For Moderate<br />

Dry Eye<br />

Evolve ® Carmellose 0.5%<br />

Evolve ® HA - Sodium Hyaluronate 0.2%<br />

Evolve ® Eyelid Wipes<br />

For Mild<br />

Dry Eye<br />

For Severe<br />

Dry Eye<br />

issues have significant implications for our<br />

hospital eye services. Dr Gale hopes to emphasise<br />

the clinical settings where a glaucoma scan<br />

is useful before referral, as well as discuss the<br />

merits of different glaucoma imaging tests,<br />

leaving time to share some cases to illustrate<br />

how best to collaborate between optometry and<br />

ophthalmology on borderline cases.<br />

I will then discuss reviews where OCT is helpful<br />

in the anterior segment and anterior chamber<br />

angle assessment as well as new uses of Avastin<br />

in the management of anterior segment<br />

neovascularisation.<br />

After lunch, local VR surgeon Dr Keith Small<br />

will explain the use of OCT in diagnosing and<br />

managing vitreoretinal cases with examples.<br />

Ending the day, therapeutic optometrist Richard<br />

Johnson and Auckland-based ophthalmologist<br />

Dr Andrew Riley will discuss OCT from a medical<br />

retinal point of view. They will cover a large<br />

range of cases where the use of OCT has assisted<br />

the diagnosis and management of patients<br />

with retinal<br />

pathology.<br />

The main<br />

focus will be<br />

on common<br />

conditions,<br />

such as<br />

diabetes and<br />

age-related<br />

macular<br />

degeneration,<br />

Dr Chris Murphy<br />

but will also<br />

include some<br />

of the newly described pathologies that have<br />

come to light in the last few years since highresolution<br />

OCTs have been utilised clinically.<br />

Delegates are welcome to bring along any<br />

cases they might like to discuss or would like an<br />

opinion on.<br />

*Dr Chris Murphy is a Hamilton-based ophthalmologist and<br />

CCLS councillor.<br />

Meet the speakers…<br />

This year’s CCLS one-day conference once again promises some very<br />

interesting topics delivered by some great speakers specialised in<br />

cornea and contact lenses (CLs). Ella Ewens asked a few of the key<br />

speakers at this year’s event about what they were presenting and<br />

why and how they came to be involved in eye health.<br />

Associate Professor<br />

Jennifer Craig<br />

Vice-chair TFOS DEWS II, Department of<br />

Ophthalmology, University of Auckland<br />

What is your main focus at this year’s<br />

CCLS conference?<br />

It will come as no surprise that dry eye disease<br />

will be my main focus at CCLS this year.<br />

Following publication of the TFOS DEWS<br />

II consensus report in July 2017, I’m aiming<br />

to provide some insight into how the latest<br />

global evidence on dry eye disease is going<br />

to affect New Zealand practice. I’ll describe<br />

how epidemiological and pathophysiological<br />

evidence over the last decade has influenced<br />

the revision of the definition and classification<br />

of dry eye disease and explain how this can<br />

be used to improve our understanding of<br />

individual patients in clinical practice and help<br />

set realistic expectations with respect to their<br />

dry eye management.<br />

Except in the most severe cases, dry eye<br />

disease is an area ideally suited to optometric<br />

management and I’m proud that we have<br />

practitioners with the desire to keep abreast of<br />

the latest developments in the field so that they<br />

can continue to offer patients optimal care.<br />

How did you get into eye health and dry<br />

eye?<br />

Eyes have always fascinated me and optometry<br />

offered me a way to follow my passion for<br />

science, eyes and caring for people. The<br />

opportunity for a research elective during my<br />

undergraduate years, with then registrar Dr.<br />

Charles McGhee, was instrumental in sparking<br />

my interest in hospital optometry and clinical<br />

research. Clinical experience had highlighted<br />

to me how common dry eye was and yet<br />

how poorly we were able to manage it. My<br />

introduction to Professor Alan Tomlinson who<br />

became my PhD supervisor and long-time<br />

mentor, further<br />

convinced me<br />

that dry eye<br />

disease was an<br />

area in desperate<br />

need of further<br />

research and in<br />

which I wanted<br />

to try to make a<br />

difference.<br />

What drives<br />

you?<br />

For me, it’s about<br />

A/Prof Jennifer Craig<br />

improving the<br />

care we provide<br />

for patients with dry eye and this requires<br />

sound scientific evidence to back up our<br />

clinical decisions. My passion is in designing<br />

and executing clinical and laboratory studies<br />

that help provide the scientific evidence that’s<br />

needed to reliably answer clinical questions and<br />

ultimately offer patients better solutions for<br />

managing their dry eye disease.<br />

Professor<br />

Heather Sheardown<br />

Chair of ophthalmic biomaterials and drug<br />

delivery, Department of Chemical Engineering,<br />

McMaster Unversity, Ontario, Canada<br />

What’s the focus of your talk at CCLS<br />

<strong>2018</strong>?<br />

Contact lenses and surfaces, including the<br />

interactions of lenses with the tear and<br />

lipid layers and friction. We have done work<br />

modifying the surface of lens materials in an<br />

attempt to minimise deleterious effects and<br />

these modifications will be described.<br />

The dropout rate for CLs is unacceptably<br />

high. In many cases, end-of-day dryness and<br />

Device Technologies<br />

Device Technologies is introducing<br />

several innovative advancements from<br />

Topcon at CCLS NZ <strong>2018</strong>. 1) Trend analysis<br />

for the Maestro OCT’s unique ‘wide<br />

scan’ encompassing macula, optic disc<br />

and ganglion cell reporting, providing<br />

normative data analysis for all these<br />

segments from one scan in each eye; 2)<br />

Hood glaucoma report with projected<br />

visual field overlays and 9x9mm OCTangiography<br />

for the Topcon Triton OCT<br />

– Topcon’s OCT-A differentiates itself<br />

by being lightning quick, having true<br />

optical tracking, giving detailed data<br />

from the choroid, penetrating through<br />

most media opacities and at the same<br />

time being very user friendly; and 3) The<br />

Topcon CA-800 topographer, which is<br />

continuing to increase in popularity as it<br />

offers great value with pupil independent<br />

infrared placido topography as well as<br />

meibography and tear film breakup time.<br />

discomfort are cited as reasons for these dropouts.<br />

We are trying to decrease this dropout rate<br />

through the modification of lens materials to<br />

improve comfort, which in itself is a somewhat<br />

subjective parameter.<br />

What are you most looking forward to at<br />

this year’s CCLS conference?<br />

I always look forward to hearing about new<br />

research and because this meeting is quite remote<br />

for me, I anticipate there will be work that is<br />

completely new to me and that is sure to spark<br />

some ideas.<br />

How did you get into your specialist area<br />

of optometry?<br />

I actually trained as a chemical engineer. My<br />

interest in optometry developed through my<br />

interest in<br />

materials and<br />

surfaces for use in<br />

the eye. Contact<br />

lenses are natural<br />

materials to<br />

study. Academic<br />

researchers rarely<br />

go beyond the<br />

lab bench, but<br />

we have been<br />

actively trying to<br />

move some of our<br />

technologies out<br />

of the academic<br />

Professor Heather Sheardown<br />

environment.<br />

Alex Petty<br />

Bay of Plenty-based optometrist and speciality CL<br />

specialist and writer<br />

What is the focus of your talk?<br />

I will be exploring some of the different clinical<br />

appearances and causes for epitheliopathy with a<br />

range of cases and conditions, from the acute to<br />

chronic, benign to concerning.<br />

So much of what we do as optometrists and CL<br />

fitters relies on monitoring corneal health. Being<br />

aware of the nuances of corneal disease and defect<br />

is crucial to managing these patients. With some<br />

of the new CL modalities that we are using these<br />

days we are seeing signs on the cornea that were<br />

not seen a decade ago, so knowing what is normal<br />

and what is not becomes very important.<br />

For<br />

Daily<br />

Eyelid<br />

Hygiene<br />

SWITCH TODAY!<br />

Dr Penny McAllum<br />

FRANZCO<br />

Eye Doctors Grand Rounds <strong>2018</strong><br />

. Wed 28th <strong>March</strong>, Novotel, Ellerslie<br />

. Wed 13th June, Ormiston Hospital<br />

. Wed 31st October, Novotel, Ellerslie<br />

Dr Shuan Dai<br />

FRANZCO<br />

. No registration fee<br />

. CPD points available<br />

. www.eyedoctors.co.nz<br />

Dr Andrew Riley<br />

FRANZCO<br />

ASCOT CLINIC (09) 520 9689 - BOTANY JUNCTION (09) 277 6787<br />

Dr Mark Donaldson<br />

FRANZCO<br />

Corneal Lens Corporation<br />

sales@corneal-lens.co.nz<br />

(03) 366 6247<br />

EYE 0810<br />

10 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong>


What attracted you to speciality CLs?<br />

I studied<br />

optometry for a<br />

range of reasons:<br />

I had exposure<br />

to the profession<br />

from childhood<br />

due to my myopia;<br />

the desire for a<br />

science-rich career<br />

with freedom to<br />

not be on call or<br />

be overly stressed<br />

at work; and being<br />

able to deal with<br />

and help people<br />

Alex Petty<br />

each day was a big<br />

draw-card.<br />

I have always been interested in specialty contact<br />

lenses, including orthokeratology and keratoconus.<br />

My interest in myopia control came about because<br />

I know first hand the problems that can result (for<br />

me, three retinal detachments!) when myopia is left<br />

to its own devices in a kid. These fields are quickly<br />

advancing, helped by some incredible technology<br />

advances, so it’s very interesting to be part of.<br />

What drives you?<br />

Other than golf you mean? I really like the feeling<br />

you get when you make a genuine difference in<br />

someone’s life; a patient with a new lens they can<br />

now see with or the management of a painful eye<br />

condition, for example. Helping colleagues with<br />

advice or experiences that enables in some small way<br />

to help their own patients is also really rewarding.<br />

Hopefully I can keep experiencing this<br />

satisfaction in optometry for many years to come!<br />

Emilie Langley<br />

Auckland-based optometrist and CL specialist<br />

What are you discussing at this year’s CCLS<br />

conference?<br />

I’m presenting<br />

the results of an<br />

orthokeratology<br />

regression study<br />

that final year<br />

optometry<br />

students have<br />

been performing<br />

for three<br />

consecutive years<br />

as their final year<br />

research project.<br />

I was one of the Emilie Langley<br />

students in the<br />

first year of the study, supervised by Grant Watters<br />

and Dr Wanda Lam, and supported by Dr Phil<br />

Turnbull and many others.<br />

We are continually learning more and more<br />

about ortho-k and… regression rates still need<br />

further research as we know that some corneas<br />

bounce back quicker than others from treatment,<br />

yet it’s currently difficult to predict for who as<br />

there are many factors involved.<br />

How did you get into optometry and CLs?<br />

I remember sitting in the St David’s Lecture Theatre<br />

in Otago and putting my friends new, black plastic<br />

Kate Sylvester low minus spectacles on and being<br />

absolutely blown away that they improved my<br />

vision. This simple act was a turning point. I<br />

was diagnosed with myopia… My interest was<br />

heightened when I took a neuro-physiology paper<br />

in the third year of my biomedical science degree<br />

where we learnt about how the senses work.<br />

That got me hooked on the visual system and led<br />

me to apply for optometry… and then to myopia<br />

control and therefore, contact lenses. I then started<br />

working with Mortimer Hirst Optometrists (with<br />

Grant Watters) and was exposed to an array of<br />

weird and wonderful contact lens fittings.<br />

What drives you?<br />

I have a continual drive to learn more. I treat<br />

each of my clients as if I was them, in the chair.<br />

By putting myself in their shoes ensures I always<br />

do my best and treat them with the respect and<br />

dignity they deserve.<br />

SPECIALITY CL FORUM<br />

A VIEW FROM THE OTHERSIDE<br />

At the end of last year, I was fortunate<br />

enough to receive the Cornea and Contact<br />

Lens Society (CCLS) Scholarship and so<br />

embarked on an educational trip to learn more<br />

about the manufacturing of rigid lenses and<br />

how they can be modified with Corneal Lens<br />

Corporation (CLC) in Christchurch.<br />

For many years, I have been meaning to make<br />

a trip down to visit Graeme Curtis and his worldclass<br />

CLC laboratory. In fact, Graeme was one of<br />

the first people who taught me about specialty<br />

lenses during a seminar at University! I recall<br />

several past conversations with colleagues from<br />

earlier generations lamenting the challenges they<br />

faced fitting specialty lenses – the inconsistencies<br />

between different orders, the limited materials<br />

and parameters available, the delay in receiving<br />

a lens. So, I know we really have it good in today’s<br />

world, where we expect a complex, yet completely<br />

accurate lens design to arrive within just a few days<br />

of ordering. So the scholarship and the trip was<br />

the perfect opportunity to learn more about what<br />

goes on behind the scenes at CLC, to improve my<br />

understanding of specialty lenses and, ultimately,<br />

the job I can do for my patients.<br />

A bit of history<br />

CLC first started making lenses in Christchurch in<br />

1971 when Graeme’s father, Ed Curtis was at the<br />

helm, and has always prided itself on staying at<br />

the forefront of CL manufacturing and technology.<br />

In the 80s, the original City Crown equipment<br />

was upgraded to modern DAC International lathe<br />

machines, allowing more complex and accurate<br />

lenses to be cut. Further upgrades continued<br />

following the disaster of the 2012 earthquake,<br />

which required CLC and its once-related Curtis<br />

Vision optometry practice to relocate to a modern,<br />

purpose built two-level laboratory in Wigram.<br />

For me, one of the coolest aspects of the CLC/<br />

Curtis Vision set-up is they have the facilities for a<br />

complex corneal patient to fly to Christchurch, have<br />

a customised-scleral contact lens fitted all in the<br />

same day. Incredible!<br />

The company has been ISO accredited since 1995<br />

and, in more recent times, has upgraded its lathes<br />

to the newest DAC ALM units. A fifth lathe will be<br />

installed in June <strong>2018</strong> to keep up with demand (who<br />

ever said rigid lenses were dead?). The ALM units are<br />

amazing to watch: the speed and precision of how<br />

a lens is cut before your eyes is highly impressive.<br />

One wonders how lenses ever got made back in the<br />

day with only hand lathes available! These multitool<br />

lathes use robotic loading and laser technology<br />

and can cut to sub-micron levels of accuracy;<br />

vital when dealing with complex orthokeratology<br />

design from fussy practitioners like yours truly.<br />

To complement the lathes, various production<br />

systems have been developed to ensure accuracy<br />

by limiting the handling of lenses by technicians.<br />

This includes auto blockers, attaching the button of<br />

contact lens material to the mount that the lathe<br />

connects to; water-soluble blocking, to reduce the<br />

use of solvents on the lens surfaces; interferometers<br />

for checking lens power and imperfections; and<br />

polishing systems that run with bladder tools rather<br />

than the cruder original methods.<br />

Some new developments<br />

Recently CLC added the modern surface treatment<br />

system HydraPEG to its offerings to provide<br />

improved wetting surfaces for rigid materials.<br />

HydraPEG creates a 40nm, hydrophilic, 90%-water<br />

polyethylene glycol (PEG) polymer coating to the<br />

surface of a lens to improve end-of-day comfort 1 ,<br />

decrease lens fogging and improve wettability.<br />

Associate Professor Patrick “Pat” Caroline from<br />

the Pacific University College of Optometry and the<br />

Department of Ophthalmology at Oregon’s Health<br />

& Sciences University, showed that HydraPEG<br />

works for soft lenses too, improving comfort scores<br />

for a group of dry eye patients in Oasys lenses 2 .<br />

Personally, I have found HydraPEG ideal for those<br />

patients with tear-film or dry eye issues and also<br />

BY ALEX PETTY*<br />

CLC’s main production room with four DAC ALM lathes. The tubes to the ceiling carry the polymer dust/fragments up into a back room for disposal<br />

those with moderate allergic eye disease,<br />

and a dry anterior lens surface that can<br />

result when those atopic keratoconics<br />

wear their lenses during all waking hours<br />

can be alleviated with this coating. For<br />

those, like me, who are a fan of regular<br />

extra strength cleaning treatments like<br />

Progent be aware, however, that these<br />

cannot be used with a HydraPEG lens – it<br />

will strip the coating right off.<br />

There were several aspects of my visit to<br />

CLC that I found particularly enlightening<br />

and interesting. The first was the number<br />

of steps that are involved in preparing<br />

even a relatively simple RGP lens. Perhaps<br />

I was foolishly naive but I had an idea<br />

that once I had hit order in my lens<br />

design software, all that would be<br />

required would be for someone at CLC<br />

to hit the big green ‘GO’ button and<br />

The effect of HydraPEG on soft contact lens comfort in a dry eye cohort<br />

CONTINUED ON PAGE 12<br />

Corneal Lens Corporation<br />

Corneal Lens is very excited about our new range of dry eye products. Our premium range, Evolve,<br />

highlights four different formulations designed to target specific areas of dry eye. The Evolve range<br />

is a generation 2 technology, with a preservative-free delivery system which gives the multi-dose<br />

benefits of a single dose unit with the familiarity of a standard bottle. It has a soft, squeezable<br />

bottle to improve ease-of-use, offering the blue tip technology designed to improve accuracy of<br />

dispensing a drop and maintaining a preservative free environment. The Evolve range consists of HA<br />

2, Carmellose 0.5%, Hypromellose 0.3% and Eyelid Wipes.<br />

Distributed by:<br />

phone: 09 443 0072<br />

email: tim@oic.co.nz<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

11


SPECIAL FEATURE: CCLS <strong>2018</strong><br />

The process of tinting custom soft lenses. The vials on the back ledge are comparison lenses for matching particularly challenging patients<br />

CONTINUED FROM PAGE 11<br />

the lathe would spit out my lens, ready to be sent<br />

up to my practice. Not so!<br />

Contact lens manufacture is a complex process<br />

with a number of crucial steps, each with a fine<br />

margin for error. CLC employ 22 staff and a good<br />

number of these are specialists at certain areas of<br />

the lens manufacturing process, from the initial<br />

lens design and programming of the parameters<br />

into the DAC programme, all the way to final edging<br />

and quality control. Seeing this in action gives me<br />

a new respect and appreciation for the quality of<br />

the finished product that ultimately we stake our<br />

reputations on as contact lens fitters. Also, did you<br />

know that soft lenses are cut from a rigid button<br />

and only expand into their correct size and shape<br />

once hydrated? Fascinating stuff!<br />

Secondly, was watching the process of custom<br />

tinting soft lenses. These low volume but highly<br />

beneficial lenses are used by practitioners around<br />

the country for a range of purposes including glare<br />

reduction for patients with iris trauma, cosmetic<br />

improvement for blind eyes with corneal opacity or<br />

scarring and simple handling tints for aphakic babies.<br />

The dye is applied to the completed clear soft<br />

lens at various diameters and positions with a<br />

special circular well-device to prevent bleeding of<br />

the tint. Each colour and lens material has a special<br />

recipe specifying how long the dye should be in<br />

contact with the lens for the desired appearance.<br />

This skill is something you can’t pick up from a<br />

textbook and learn. The technicians creating these<br />

lenses are as close as you can get to artists in the<br />

contact lens world!<br />

The lighter side of lens work<br />

Graeme Curtis (top left) and the CLC team about to embark on an adrenaline filled ride after a busy 2017<br />

A weekend away wouldn’t be complete without a<br />

bit of fun. Graeme was kind enough to invite me<br />

out for his team’s Christmas party: jet-boating up<br />

the spectacular Waimakariri river (the birthplace of<br />

the modern jet boat) in superb 30°C+ Canterbury<br />

heat. Needless to say, the cooling spray from the<br />

360° Hamilton turns were most welcome!<br />

A huge thank you must go out to Graeme, Alan<br />

and the rest of CLC team for being so welcoming<br />

and giving up their time and expertise to teach me<br />

a few things. It was clear from my visit that CLC go<br />

to great lengths to support our profession and to<br />

help our patients. Cheers guys!<br />

And also thanks to the CCLS NZ committee for<br />

deeming me worthy of the scholarship! It is great<br />

that we have such a collegial group of interprofession<br />

anterior eye people here in New Zealand<br />

and I’m looking forward to catching up with you all<br />

at the CCLS NZ one-day conference in <strong>March</strong>.<br />

References<br />

1. Walker M, Redfern R. Scleral lens surface coating improves<br />

vision and comfort. Poster presented at the 8th International<br />

Tear Film and Ocular Surface Society (TFOS), Sept 2016,<br />

Montpellier, France.<br />

2. Caroline P, Lampa M, Kinoshita B, Walker M, Andre M, Kojima<br />

R, Zheng F. Hydra-PEG: A solution to contact lens discomfort,<br />

Poster presented at 2015 GSLS conference, Las Vegas.<br />

About the author:<br />

*Alex Petty is a New Zealand optometrist based at Bay Eye<br />

Care in Tauranga, with a particular interest and knowledge in<br />

speciality contact lenses, ortho-k and myopia control. Alex will<br />

be giving a talk about some of his more interesting cases at the<br />

CCLS NZ one-day conference on 18 <strong>March</strong> in Wellington (see<br />

p8-10, for more).<br />

OptiMed<br />

Visit OptiMed NZ at CCLS <strong>2018</strong> and see<br />

what goodies Craig has on display! Front<br />

and centre will be the REVO OCT by<br />

Optopol, a world leading machine which<br />

will give you quick, crisp images, now with<br />

added features including optical biometry<br />

and angiography. Don’t fret if you’re after<br />

a product and it’s not on our stand, just<br />

ask Craig or get in contact with OptiMed<br />

NZ (see the OIG or ad on p13 for details).<br />

With an integral event like CCLS you know<br />

there will be some great deals to be had,<br />

so come on down and see what we have<br />

to offer!<br />

Designs For Vision<br />

Designs For Vision is looking forward to<br />

an exciting <strong>2018</strong> with some new products<br />

expected to deliver great results for<br />

patients and providers. Dry eye treatment<br />

will continue to be a strong growth area<br />

and there is already a lot of interest<br />

in the Eye-Light intense pulsed light<br />

(IPL) system. Its gel-free, low-running<br />

cost technology is unique in the field<br />

and complements existing treatment<br />

options. In the ophthalmic surgical area,<br />

Rayner is rolling out more additions to its<br />

RayOne preloaded IOL range including the<br />

remarkable new trifocal lens, and Hoya<br />

now has the Vivinex Toric IOL range.<br />

A step-by-step guide to making a rigid lens<br />

l The lens order is received and all<br />

parameters, including front surface<br />

curvatures and edge profiles, are<br />

programmed in to the lathe software.<br />

l The uncut lens button (the cylinder<br />

of rigid lens material) is prepared<br />

for cutting by firstly being precisely<br />

attached onto the mount that the<br />

lathe attaches to, otherwise known as<br />

blocking.<br />

l The posterior lens surface, including<br />

the base curve, is cut first. The DAC ALM<br />

lathe can rotate the lens at speeds up to<br />

10,000RPM during cutting.<br />

l The back surface is then polished<br />

using special automated abrasive water<br />

bladders to ensure even polishing and<br />

no sharp surfaces.<br />

l An inspection of the back surface is<br />

made. If everything is satisfactory the<br />

block is transferred to the other surface.<br />

l The front surface is cut and any<br />

laser engravings or axis markings are<br />

accurately applied.<br />

l The front surface is polished, six lenses<br />

at a time. Different polishing machines<br />

exist for corneal lenses and larger sclerals.<br />

l The lens is removed from the block<br />

and ultrasound cleaned.<br />

l Centre thickness and power is<br />

verified. If required, small changes to<br />

power can be made with a manual<br />

alteration tool.<br />

l Image quality is then inspected with<br />

aberrometry.<br />

l Final edging and adjustments are<br />

then done manually to finish the lens, if<br />

required.<br />

l After a short soak in wetting solution,<br />

the lenses have a final inspection<br />

before being passed along for plasma or<br />

HydraPEG coating.<br />

l Finally, the appropriate labels are<br />

generated and the completed lens is<br />

sent to customer services for shipping.<br />

12 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong>


A site for sore eyes<br />

CQ Hotel in Wellington has become New Zealand’s first hotel to be awarded a<br />

‘Be. Accessible’ rating for the way it caters for physically, visually and audiblyimpaired<br />

people. Jai Breitnauer checked it out.<br />

The building housing Wellington’s Comfort and<br />

Quality Hotel, or CQ Hotel, has a long history<br />

of lending a helping hand. A character-packed<br />

structure, in the heart of the capital’s vibrant Cuba<br />

Street, the site was originally owned by Major James<br />

Paul and his philanthropist daughter Annette, who<br />

worked tirelessly with the Salvation Army to house<br />

displaced women. They donated the site for the<br />

building to the Paulina Resque Home in 1894, which<br />

later became a Salvation Army ‘People’s Palace’, a safe<br />

and alcohol-free hostel for travellers.<br />

In 1990, the building was acquired by Port Nic<br />

Properties, which gave it a full refurb, bringing it up<br />

to earthquake safety standards. Further work was<br />

then undertaken in 2005, when the company joined<br />

the Choice Hotels chain to turn it into the world<br />

class hotel and conference centre it is today. It’s ‘Be.<br />

Accessible’ journey, however, began just a couple of<br />

years ago when forward-thinking general manager,<br />

Oliver Lacoua, felt CQ could take its mantra of quality<br />

and comfort one step further and build on the site’s<br />

philanthropic past.<br />

The hotel is now completely fitted out for both<br />

able-bodied guests and those with physical, auditory<br />

and visual challenges to make their stay easier and<br />

more comfortable. As well as a lower check-in desk<br />

and accessible car park, there are nine rooms with<br />

extra space and accessible ensuites. The hotel also<br />

offers iBeacons, which enables mobile apps (both iOS<br />

and Android) to understand their user’s position on<br />

a micro-local scale and deliver contextual content to<br />

them based on exactly where they are. The iBeacons<br />

work with BlindSquare, a popular accessible GPS-app,<br />

now being promoted by Wellington City Council, that<br />

was specifically developed for the blind and visually<br />

impaired to describe their environment, announce<br />

points of interest and other things, such as shops and<br />

street intersections (see box).<br />

The hotel’s menu is currently being adapted to braille<br />

and it’s working on introducing braille information<br />

cards. For audibly-impaired guests, key staff have also<br />

been trained in sign language. Staff have also had<br />

special training to help customers with additional<br />

needs in cases of an emergency, such as an earthquake.<br />

The lifts go right to the car parking level, the conference<br />

facilities are all on the ground floor and the public<br />

areas are all fully accessible.<br />

Although Lacoua has now moved on to pastures new,<br />

the CQ is continuing its commitment to providing a<br />

good quality service to people with disabilities and are<br />

working on expanding the services they offer.<br />

A comfortable, quiet and pleasant place to stay, in a<br />

great location with exceptionally helpful staff, who go<br />

that extra mile for people with disabilities, I couldn’t<br />

recommend it more.<br />

BlindSquare: the seeing app<br />

BlindSquare is a new Wellington-based project that<br />

is aimed at customers and visitors who are blind<br />

or have low vision or a print disability. Using the<br />

BlindSquare Event iPhone navigation app and Kontakt.<br />

io beacons, the service helps visually impaired people<br />

in Wellington explore the city with independence.<br />

As app-users pass by shops and businesses that are<br />

‘BlindSquare enabled’, the app provides a spoken<br />

description of the business, including its name, what<br />

goods or services it provides and the shop layout. The<br />

app also provides users with other information such<br />

as the names of the roads they are walking along, or<br />

where the bus stops are. It does this by communicating<br />

with the various beacons installed around the city and<br />

at participating businesses.<br />

For more information visit https://wellington.govt.nz/<br />

services/community-and-culture/accessibility-services/<br />

blindsquare-ibeacons<br />

Wellington’s CQ Hotel now fully-equipped to help visually-impaired patrons<br />

BOOK REVIEW<br />

Ryan’s Retina, sixth edition<br />

By Drs Andrew P. Schachat, Charles P. Wilkinson, David R. Hinton,<br />

SriniVas R. Sadda and Peter Wiedemann<br />

REVIEWED BY DR MONIKA PRADHAN*<br />

Ryan’s Retina is recognised internationally as one<br />

of the most comprehensive resources for the study<br />

of retinal diseases and hence I approached this<br />

textbook with excitement and eager anticipation.<br />

True to its reputation, it did not disappoint and I<br />

was soon engrossed in its crisp new pages.<br />

Since Dr Stephen Ryan first published it in<br />

1989, the authors have tried to produce new<br />

editions every five years to keep up with the<br />

rapid advancements in medical diagnosis and<br />

treatment. This sixth edition has aimed to add<br />

contemporary information with new chapters in<br />

each section of the book while removing the more<br />

dated aspects that have now become obsolete.<br />

With 160 chapters over three volumes and 2681<br />

pages, this is definitely not light bedtime reading.<br />

However, as the authors propose, it encompasses<br />

all aspects of retinal disorders, including retinal<br />

imaging and diagnostics, basic science and<br />

translation to therapy, medical retina and uveitis,<br />

surgical retina and tumors of the retina, choroid<br />

and vitreous. Over 300 retinal experts, from all<br />

over the world, have contributed as authors. In<br />

addition, there is a very handy eBook to entice<br />

digital readers that can be accessed on multiple<br />

devices and has additional online material<br />

together with 40 videos.<br />

There are beautiful illustrations and clinical<br />

photographs included throughout the text,<br />

complementing the subject matter. The imaging<br />

section has been updated with the latest<br />

diagnostic techniques including autofluorescence<br />

imaging, OCT angiography, wide-field imaging<br />

and even intraoperative OCT. The medical retina<br />

volume is replete with the usual suspects such<br />

as age-related macular degeneration, diabetic<br />

retinopathy and retinal vascular diseases, but<br />

also has some very interesting chapters on<br />

rarer entities, such as drug toxicity, pregnancyrelated<br />

retinal pathology and traumatic<br />

chorioretinopathies. The surgical retina<br />

chapters are<br />

comprehensive,<br />

highlighting<br />

various<br />

challenges<br />

encountered<br />

during<br />

vitreoretinal surgery<br />

and successful<br />

strategies to manage them<br />

effectively. While the<br />

majority of the surgical<br />

videos are of high quality and accompanied by<br />

audio narration. I particularly found the videos<br />

of transscleral resection of choroidal melanoma,<br />

removal of a large intraocular glass foreign body<br />

and implantation of an Argus II array in a patient<br />

with rod-cone dystrophy quite fascinating.<br />

My only minor criticism of this publication<br />

would be that the uveitis section is slightly<br />

lacking with the omission of a major entity<br />

namely Behçets disease. Manifestations of newer<br />

viral afflictions such as Ebola and Dengue are<br />

also missing. In addition, a chapter on recent<br />

developments in immunomodulatory treatments<br />

would have been quite useful. However, it can be<br />

argued that these topics would be more in the<br />

domain of an exclusive uveitis text.<br />

In summary, the sixth edition of Ryan’s Retina<br />

is an excellent reference text for medical and<br />

surgical retina specialists, trainees undertaking<br />

retinal subspecialty fellowships as well as any<br />

ophthalmologist wanting to quickly update their<br />

knowledge on a particular retinal pathology. It<br />

should certainly occupy a prime position in all<br />

institutional ophthalmology libraries.<br />

*Dr Monika Pradhan is a consultant ophthalmologist at<br />

Greenlane Clinical Centre and the Manukau Superclinic<br />

in Auckland, New Zealand, specialising in medical retina<br />

and vitreoretinal surgery. She also practices at Eye Surgery<br />

Associates in Auckland.<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

13


Focus<br />

on Business<br />

Health and safety update -<br />

What you need to do<br />

An optometrist or ophthalmologist’s<br />

practice is a relatively low-risk business,<br />

however, you have a duty to ensure<br />

you can demonstrate that you have taken the<br />

necessary steps to understand what the risks to<br />

workers’ health and safety (H&S) are, and you<br />

have a plan in place to manage this.<br />

Implementing a HSMS<br />

A requirement under the Health and Safety<br />

at Work Act 2015 (HSWA) is to have a H&S<br />

Management System (HSMS) in place. An<br />

effective HSMS results from organisational<br />

leadership and commitment. Everyone has a<br />

duty to work safely, but you still need to manage<br />

and coordinate the overall health and safety<br />

programme of the organisation.<br />

A HSMS is the framework for doing this and<br />

needs to include the following key elements:<br />

• Safety leadership and commitment – setting<br />

out how you value safety, expectations and<br />

accountability. This is the H&S policy which<br />

needs to be signed by the owner/CEO and<br />

displayed for all workers to see<br />

• Risk and hazard management – your practice’s<br />

process for hazard identification, risk assessment<br />

and management of actual and potential<br />

hazards. A risk register should be completed<br />

detailing all the practice’s risks and potential<br />

hazards and how they are being controlled<br />

• Emergency procedures – a record of the<br />

planning, training and testing (drills) for<br />

potential emergencies that may arise<br />

• Information, training and supervision – how<br />

you support your employees to work safely. This<br />

includes staff inductions, training registers and<br />

documented, safe-work procedures<br />

• Incident and accident reporting – how you<br />

report and investigate incidents and accidents to<br />

identify causes of harm and implement actions<br />

to prevent similar events<br />

• Injury management – the practice’s<br />

documented processes for ensuring injured<br />

persons are properly cared for<br />

• Worker engagement and participation – how<br />

you have involved your employees who are<br />

exposed to the risks in managing those risks.<br />

Includes appointing an effective H&S Committee<br />

• Performance and measurement – to<br />

demonstrate you know how your safety system<br />

is performing and how your practice’s risks are<br />

being managed<br />

It is not necessary to invest in a specific HSMS<br />

software application as the same results can be<br />

achieved using Microsoft Word or Excel.<br />

Hazard and risk management<br />

The most critical element is effective hazard<br />

and risk management. This is about identifying<br />

hazards that have the potential to cause harm,<br />

so are “risks” to your employees or visitors, how<br />

you’ve managed to eliminate them or, at least,<br />

what steps you’ve taken to reduce the risks. The<br />

key stages in hazard and risk management are:<br />

1. Identification of hazards<br />

2. Assess the hazards’ risks<br />

3. How the hazards’ risks are being controlled<br />

4. Understanding and documenting the residual<br />

risks of the hazards identified<br />

5. Monitoring hazards and controls<br />

6. Reviewing hazards and controls<br />

Identifying hazards<br />

The first step is to identify hazards. A simple<br />

approach to this is a method called STEP: Site –<br />

where you work; Task – what you do and how<br />

you do it; Equipment – what you use or are<br />

exposed to; and PPE, what protective equipment<br />

or clothing is worn.<br />

The most common hazards are:<br />

• Manual handling – lifting objects, twisting<br />

• Slips, trips and falls – bad housekeeping or a<br />

poorly kept practice environment<br />

• Falling objects – items falling from storage<br />

racks etc.<br />

• Cuts from equipment used or glass<br />

BY LIAM DENTON*<br />

• Breathing in dust, eg. when using grinding or<br />

polishing equipment<br />

• Eye injuries – particles from machine use<br />

which get caught in the eye<br />

• Fatigue – from working long hours<br />

• Bullying / stress – ineffective employee<br />

management or reporting structures<br />

It is essential to engage your employees in the<br />

process of identifying and managing hazards<br />

and to encourage them to discuss any discomfort<br />

they may experience when undertaking their<br />

duties or carrying out their work.<br />

Assessing the risks<br />

After the hazards have been identified, you need<br />

to assess each hazard to find out what risk it<br />

may pose to workers. This means assessing the<br />

probability (chance) and consequences (impact)<br />

via a Risk Matrix.<br />

Controlling the hazard risk<br />

Once the hazards have been identified and their<br />

risks assessed, you must decide which control<br />

measures are most appropriate. The hierarchy of<br />

controls is as follows:<br />

1. Eliminate the hazard<br />

2. Minimise the risk by:<br />

a. Substituting the hazard with one less<br />

harmful<br />

b. Isolating the hazard from workers<br />

c. Engineering controls such as guards, timelocks<br />

etc.<br />

3. If the risk is still present, then apply<br />

administration controls such as:<br />

a. Signage<br />

b. Training / supervision<br />

c. Standard Operating Procedures (SOPs)<br />

d. Inspections<br />

4. If the risk remains then instigate the use of<br />

personal protective equipment (PPE) eg. eye<br />

protection, face masks, gloves etc.<br />

Monitoring and review<br />

Establish a H&S Committee that includes<br />

employees and meets regularly (at least<br />

quarterly) to review/investigate incidents, new<br />

hazards, determine where controls are effective<br />

and any other H&S matters.<br />

Employees who work from home<br />

Your practice also has a responsibility to ensure<br />

that work done at home is done in a safe manner.<br />

If the work being done is primarily on a computer,<br />

then there should be a workspace, setup<br />

appropriately for this to be done, reflecting the<br />

same standard as if the employee was at work.<br />

However, the practice’s responsibility doesn’t<br />

extend beyond the employee’s home workspace<br />

or to other activities carried out in the home.<br />

Summary<br />

While our working practices have changed in<br />

many ways, it is still absolutely the case that the<br />

responsibility for managing risk rests with those<br />

who create the risk. Good H&S goes hand-inhand<br />

with good business and organisational<br />

performance and building a good H&S culture<br />

in any organisation requires strong leadership.<br />

Finally, workforce engagement and involvement<br />

is essential to succeed in embedding H&S in the<br />

fabric of an organisation.<br />

For more on PPE eyewear see p18 and for a<br />

lighter look at safety see Chalkeyes presents on<br />

p22<br />

ABOUT THE AUTHOR:<br />

*Liam Denton is a principal<br />

at Safety Associates (www.<br />

safetyassociates.co.nz) and a<br />

member of the NZ Institute of<br />

Safety Management. To get in<br />

touch on any matters relating<br />

to H&S call Liam on 0275 684<br />

216 or email him at, liam@<br />

safetyassociates.co.nz<br />

AI and ophthalmology<br />

BY DR SHENG CHIONG HONG*<br />

From driverless cars to robot surgery, it’s clear<br />

this is the dawn of the age of machines, and<br />

medicine is becoming a primary focus for this<br />

artificial intelligence (AI) revolution.<br />

In 2011, IBM (International Business Machines<br />

Corp.) introduced IBM Watson Health, to<br />

complement its first artificial question-answering<br />

supercomputer Watson, combining AI, or machine<br />

learning, and sophisticated analytical software.<br />

Watson Health’s processing abilities encompass<br />

a comprehensive package of cognitive healthcare<br />

solutions utilising big health data, machine<br />

learning and cloud analytics to provide what’s<br />

now commonly called “precision medicine” –<br />

the customisation of healthcare, with medical<br />

decisions, treatments, practices and/or products<br />

tailored to an individual patient.<br />

Since then the number of companies and<br />

researchers globally who participate in healthcare<br />

machine learning has soared tremendously.<br />

But, despite the rapid development and positive<br />

publicity, this new smart health tech is still being<br />

met with a degree of criticism and scepticism<br />

among healthcare practitioners as there is very little<br />

good quality, evidence-based results data available.<br />

This is partly due to the lack of peer-reviewed<br />

published evidence and deep learning (machine<br />

creators’ attempts to mimic the thinking part of our<br />

brains to produce ‘real’ AI) being labelled as “black<br />

box” systems, ie. either they’re too complicated to<br />

understand or consisting of proprietary algorithms<br />

manufacturers refuse to share or explain.<br />

AI and diabetic retinopathy detection<br />

In 2016, Gulshan et al published a landmark paper<br />

in the field of clinical artificial intelligence 1 . The<br />

study, which was funded by Alphabet (Google’s<br />

parent company), involved the development of a<br />

deep learning algorithm for the detection of diabetic<br />

retinopathy (DR) in retinal fundus photographs.<br />

It used a clinical data set totalling 128,175 retinal<br />

images, which were graded three to seven times for<br />

diabetic retinopathy, diabetic macular oedema and<br />

image quality by a panel of 54 ophthalmologists and<br />

senior ophthalmology residents.<br />

The research team used Inception-v3 architecture<br />

as their deep learning neural network. This was<br />

“trained” to make predictions as to whether the<br />

DR in the image was mild, moderate, severe or<br />

proliferative DR. The resultant algorithm was then<br />

validated with two separate data sets (EyePACS-1<br />

and Messidor-2). Using the first operating cut<br />

point with high specificity, the EyePACS-1 yielded<br />

a sensitivity of 90.3% and specificity of 98.1%.<br />

For Messidor-2, the sensitivity was 87% and the<br />

specificity was 98.5%. Using a second operating<br />

point with high sensitivity in the development<br />

set for EyePACS-1, the sensitivity was 97.5% and<br />

specificity was 93.4% and for Messidor-2, the<br />

sensitivity was 96.1% and specificity was 93.9%.<br />

Thus, the authors concluded the algorithm based<br />

on deep machine learning had high sensitivity and<br />

specificity for detecting referable DR.<br />

The positive findings from this Google-funded<br />

study have led to a major partnership being<br />

formed between Verily (the life sciences division of<br />

Google) and Nikon. The plan is to combine Nikon’s<br />

Optos wide-field retinal imaging technology with<br />

Verily’s machine-learning technology to develop<br />

the next generation of affordable retinal cameras<br />

incorporating diagnostic AI, and thus to be able to<br />

diagnose DR and other retinal diseases far earlier<br />

than is currently possible.<br />

Google’s artificial intelligence is far from magic<br />

or new, however. The concept of machine learning,<br />

and more specifically deep learning, has been<br />

around for over 30 years. But it’s only in the last<br />

decade that computing power has actually been<br />

up to the task, following the introduction of<br />

powerful graphics processing units (GPUs).<br />

Also Google is not alone in its focus on AI as the<br />

way of the future, with other companies such as<br />

Microsoft, Nvidia, IBM and Amazon introducing<br />

GPUs into the cloud to enable better machine<br />

learning.<br />

In New Zealand, Dr Nishan Ramachandran and his<br />

team evaluated a deep learning diabetic screening<br />

system, Visiona Intelligent, with diabetic retinal<br />

photos acquired from the Otago diabetic screening<br />

database (485 photos) 2 . The Visiona Intelligent<br />

system was developed by Visiona Medtech in Hong<br />

Kong and was “trained” with a dataset of more<br />

than 100,000 fundus photographs, with more than<br />

30% graded as severe enough to be referred to<br />

an ophthalmologist. The Visiona system was also<br />

used to evaluate the Messidor database. Visiona’s<br />

ability to detect referable DR was (area under curve)<br />

0.901 for the Otago database and 0.98 for the<br />

Messidor database, so the results were comparable<br />

to the system developed by Google. However, the<br />

AI – the next major technological disruption for ophthalmology and<br />

optometry<br />

system is not capable of more specific tasks such as<br />

detecting other common ocular pathologies such as<br />

vessel-occlusive diseases, macular degeneration or<br />

glaucoma.<br />

The use of convolutional neural networks<br />

(CNN) in machine learning has been grabbing the<br />

headlines globally. The idea of CNNs come from<br />

experiments on cats’ visual cortexes, where it was<br />

discovered that lower level neurons in the cortex<br />

detect lower level features, while higher level<br />

neurons in the cortex find higher level features.<br />

This is how humans also classify images, by<br />

learning different features through example.<br />

At present, most machine learning is still<br />

supervised learning, where we give a machine<br />

labelled data, but it’s expected a time will come<br />

when unsupervised learning will supersede<br />

supervised learning, allowing machines to teach<br />

themselves through experience.<br />

AI and other eye diseases<br />

Fundal photograph auto-diagnosis is not the only<br />

domain where deep learning can tackle areas<br />

efficiently. Several investigators have published<br />

promising results with AI in other areas such as agerelated<br />

macular degeneration AMD) and glaucoma.<br />

Burlina et al published an abstract on the use of<br />

deep learning for recognition of age-related macular<br />

degeneration (AMD) 3 and presented on it at the 13th<br />

International Symposium on Biomedical-Imaging in<br />

Prague in 2016. In this study the AI neural network<br />

was tested using over 5600 images from the US<br />

National Institutes of Health Age-Related Eye Disease<br />

Study (AREDS) dataset with preliminary results for<br />

accuracy ranging between 92% and 95%.<br />

Another deep learning and AMD study by the<br />

ophthalmology department at the University of<br />

Washington’s School of Medicine extracted 2.6<br />

million OCT images from American electronic<br />

medical records and used a total of 80,839 images<br />

(41,074 from AMD and 39,765 from normal<br />

patients) for training 4 . Again, investigators<br />

reported a high accuracy of 93.45%, with a<br />

sensitivity of 83.82% and a specificity of 96.40%.<br />

An interesting and eye-catching system called<br />

ALADDIN (automatic feature learning for glaucoma<br />

detection based on deep learning) was developed<br />

by a team from Singapore 5 . Led by Professor Tien<br />

Yin Wong, the system was designed with a deep<br />

learning framework designed to generate a multilayer<br />

neural network of both linear and non-linear<br />

transformations of the data to yield more abstract<br />

and useful representations. The system was tested<br />

extensively on the ORIGA and SCES datasets<br />

with results showing area under curve (AUC)<br />

of the receiver operating characteristic curve in<br />

glaucoma detection of 0.838 and 0.898 in the two<br />

databases, leading the authors to conclude that<br />

the system performs better than present state-ofthe-art<br />

algorithms and can be used for glaucoma<br />

detection and diagnosis.<br />

Asaoka et al published a paper on the use of deep<br />

learning for detecting pre-perimetric glaucoma<br />

with standard automated perimetry 6 . A total of 171<br />

pre-perimetric glaucoma visual fields were obtained<br />

and tested against 108 healthy visual fields. The<br />

authors compared the results of deep feed-forward<br />

neural network (FNN) with older machine learning<br />

classifiers, such as random forests (RF), gradient<br />

boosting, support vector machine (SVM) and neural<br />

network (NN). The authors reported a 92.5% of AUC<br />

value for deep FNN and concluded that the deep<br />

learning training technique can distinguished preperimetric<br />

glaucoma visual fields from health visual<br />

fields with very high accuracy.<br />

Another glaucoma detection system based on a<br />

deep learning framework called Glaucoma-Deep<br />

was published by Qairsar Abbas 7 . A total of 1200<br />

retinal images were selected from both public<br />

and private datasets (600 normal and 600 with<br />

glaucoma). The author reported a high accuracy<br />

of 99% with sensitivity of 84.5% and specificity of<br />

98.01%. So far this is the only reported system with<br />

the greatest performance in detecting glaucoma<br />

based purely on retinal images.<br />

Potential applications of deep learning<br />

There are no limits to the types of conditions and<br />

diagnoses that deep learning techniques can be<br />

14 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong>


applied to. The same technology can be applied<br />

to a variety of conditions such as retinopathy of<br />

prematurity, retinitis pigmentosa, keratoconus<br />

(corneal topography), vessel-occlusive diseases and<br />

others. It can also be added to existing ophthalmic<br />

systems, such as retinal cameras, corneal<br />

topographers and OCT scanners.<br />

The use of deep learning is also not limited to<br />

image classification. It started off with numerical<br />

analysis and is extremely useful in the analysis of<br />

big data. From a numerical standpoint, optimising<br />

biometry for cataract surgery is well within its<br />

capability. Deep learning also has the potential to<br />

outperform all existing methods of determining<br />

optimal intra-ocular lens power and can be applied<br />

to other predictive tasks, such as estimating the<br />

individual risk of cataract surgery, progression of<br />

disease or prognosis.<br />

Another breakthrough in the use of deep<br />

convolutional neural networks for image superresolution<br />

is SRGAN, a generative adversarial<br />

network (GAN) for image super-resolution (SR) 8 .<br />

A highly challenging task of estimating a highresolution<br />

image from its low-resolution counterpart<br />

is referred to as super-resolution. For example,<br />

researchers may have been given a dataset of clinical<br />

images with lower resolution due to constrains such<br />

as storage size and internet bandwidth. With SRGAN,<br />

these images can be digitally optimised making<br />

them hard to distinguish from the original RAW files.<br />

SRGAN may also have a role in telemedicine, where<br />

clinical images are usually compressed for digital<br />

transfer to optimise speed.<br />

For numerical and big data analysis, IBM’s Watson<br />

offers a range of solutions on the cloud including<br />

a capability for image classification, while Neural<br />

Designer (Artificial Intelligence Techniques Ltd,<br />

Spain), a desktop application, offers an advanced<br />

analytics platform for dealing with big data without<br />

programming or building block diagrams, though<br />

has no image classification capability.<br />

Public retinal image databases<br />

There is no doubt that an important requirement for<br />

deep learning is high quality data and a lot of it. The<br />

accuracy of a deep neural network depends on three<br />

major factors: the quality of the data, the quantity of<br />

the data, and the types of training implemented.<br />

Health technology and AI is becoming the new<br />

gold rush, and good quality data can be more<br />

valuable than gold. Fortunately, for beginners<br />

who would like to start experimenting with deep<br />

learning, there is now a large number of high<br />

quality datasets available publicly (see Table 1).<br />

New Zealand-Based Deep Learning Platform – MedicMind<br />

It can be difficult for clinical<br />

researchers to make use of deep<br />

learning in their research since<br />

conventional deep learning<br />

frameworks such as Tensorflow,<br />

Caffe, Theano and Torch<br />

require advanced knowledge of<br />

programming languages like C++<br />

and Python. This would usually mean<br />

the services of a software engineer,<br />

or programmer with experience<br />

in one of the above deep learning<br />

frameworks, is needed who can be<br />

expensive and hard to find. MedicMind, however,<br />

offers a solution for clinical researchers with no<br />

prior knowledge of programming or coding. It is<br />

a free-to-use web-based system using Google’s<br />

deep mind framework Tensorflow with the best<br />

References<br />

1. Gulshan v, Peng L, Coram M, et al. Development and Validation<br />

of a Deep Learning Algorithm for Detection of Diabetic<br />

Retinopathy in Retinal Fundus Photographs. JAMA. 2016; 316<br />

(22): 2402-2410. Available from https://jamanetwork.com/<br />

journals/jama/fullarticle/2588763<br />

2. Ramachandran N, Hong SC, Sime MJ, Wilson G. Diabetic<br />

Name Description Available from (website)<br />

ORIGA<br />

650 images acquired through the Singapore Malay Eye Study (SiMES), http://imed.nimte.ac.cn/Origa-650.html<br />

includes 168 glaucomatous and 482 non-glaucoma images<br />

High-resoltuon<br />

fundus (HRF) image<br />

database<br />

15 images of healthy patients, 15 images of DR patients and 15 images of<br />

glaucomatous patients<br />

https://www5.cs.fau.de/research/data/fundus-images/<br />

DRIVE<br />

Messidor<br />

40 images: 33 normal and seven with signs of mild/early diabetic<br />

retinopathy<br />

1200 retinal images graded for normal, DR and risk of diabetic macular<br />

oedema<br />

https://www.isi.uu.nl/Research/Databases/DRIVE/<br />

download.php<br />

http://www.adcis.net/en/Download-Third-Party/<br />

Messidor.html<br />

Messidor-2 An extension of the Messidor database, containing 1748 retinal images http://latim.univ-brest.fr/indexfce0.html<br />

DIARETDB0 130 retinal images: 20 normal and 110 with signs of diabetic retinopathy http://www.it.lut.fi/project/imageret/diaretdb0/<br />

STARE<br />

400 retinal images with a large variety of diagnoses: emboli, retinal http://cecas.clemson.edu/~ahoover/stare/<br />

vessel occlusive diseases, DR, hypertensive retinopathy and choroidal<br />

neovascularisation<br />

DIARETDB1<br />

89 retinal images: 84 with at least mild non-proliferative signs of DR and http://www.it.lut.fi/project/imageret/diaretdb1/<br />

five normal<br />

EyePacs DR 35,126 retinal images from diabetic screening programmes https://www.kaggle.com/c/diabetic-retinopathydetection/data<br />

Table 1. Publicly available retinal image databases<br />

MedicMind is a web-based platform<br />

for image classification using<br />

Tensorflow deep learning framework<br />

practice convolutional network,<br />

Inception V-3. The user interface<br />

has been designed to be as intuitive<br />

as possible with a simple drag and<br />

drop approach for importing image<br />

datasets. Researchers can easily<br />

develop state-of-the-art, deep<br />

neural networks with the platform<br />

with rich statistical analysis such<br />

as specificity, sensitivity and ROC<br />

curves. Statistics can also be easily<br />

exported for use in research and<br />

the deep neural network can be<br />

shared and exported as an external web-based<br />

app for external use, so a DR screening system<br />

can be trained and developed for resource-limited<br />

regions with minimal cost and time. MedicMind is<br />

available from http://www.medicmind.tech/ ▀<br />

Retinopathy Grading Using Deep Neural Network. Clinical and<br />

Experimental Ophthalmology. 2017. doi:10.1111/ceo 13056.<br />

Available from http://onlinelibrary.wiley.com/doi/10.1111/<br />

ceo.13056/abstract<br />

3. Burlina P, Freund D E, Joshi N, et al. Detection of age-related<br />

macular degeneration via deep learning. 2016 IEEE 13th<br />

International Symposium on Biomedical Imaging (ISBI). 2016.<br />

Access available from http://ieeexplore.ieee.org/abstract/<br />

document/7493240/?reload=true<br />

4. Lee CS, Baughman DM, Lee AY. Deep Learning Is Effective for<br />

Classifying Normal versus Age-related Macular Degeneration<br />

OCT Images. Ophthalmology Retina. 2017; 1(4) : 322 – 327.<br />

Available from http://www.ophthalmologyretina.org/article/<br />

S2468-6530(16)30174-9/pdf<br />

5. Chen X, Xu Y, Yan S et al. Automatic Feature Learning for<br />

Glaucoma Detection Based on Deep Learning. International<br />

Conference on Medical Image Computing and Computer<br />

Assisted Intervention. 2015. pp 669 – 677. Available from<br />

https://link.springer.com/chapter/10.1007/978-3-319-24574-4_80<br />

6. Asaoka R, Murata H, Araie M. Detecting Preperimetric Glaucoma<br />

with Standard Automatic Perimetry Using a Deep Learning<br />

Classifier. Ophthalmology. 2016. 123(9): 1974-1980. Available<br />

from https://www.ncbi.nlm.nih.gov/pubmed/27395766<br />

7. Abbas Q. Glaucoma-Deep : Detection of Glaucoma Eye Disease<br />

on Retinal Fundus Images using Deep Learning. International<br />

Journal of Advanced Computer Science and Applications. 2017;<br />

8(6). Available from https://pdfs.semanticscholar.org/fbc2/7038b<br />

9c111dad2851397047c6230ece79c23.pdf<br />

8. Ledig C, Theis L, Huszar F et al. Photo-Realistic Single Image<br />

Super-Resolution Using a Generative Adversarial Network.<br />

ARXIV. arXiv:1609.04802 Available from https://arxiv.org/<br />

abs/1609.04802<br />

About the author<br />

*Dr Sheng Chiong Hong (better known<br />

as Hong) is an ophthalmology registrar<br />

at Dunedin Hospital and co-founder and<br />

CEO of social eye care enterprise oDocs<br />

Eye Care and medical technology firms<br />

Vise Medic and Sober-Eye AV.<br />

Rethink glaucoma management<br />

The power of simplicity 1<br />

Reference: 1. Allergan XEN directions for use.<br />

The XEN ® Gel Implant is intended to reduce intraocular pressure in patients with primary open angle glaucoma where previous medical treatments have failed.<br />

Always refer to full instructions before use. Adverse events should be reported to your local Allergan office, Australia 1800 252 224 or New Zealand 0800 659 912.<br />

XEN ® is a registered trademark of AqueSys, Inc., an Allergan affiliate. Trademark of Allergan, Inc. ©2017 Allergan. All rights reserved. Allergan Australia Pty Ltd, 810 Pacific Highway,<br />

Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. NZBN 9429 0321 20171. ANZ/0016/2017e. DA1731CB. Date of Preparation: October 2017.<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

15


for optometrists and eye care professionals<br />

with<br />

Professors Charles<br />

McGhee & Dipika Patel<br />

Series Editors<br />

Ophthalmic drug development<br />

BY DR ILVA RUPENTHAL*<br />

Developing new drugs for the treatment of<br />

ocular diseases can be a time-consuming<br />

and costly undertaking. The trip from<br />

laboratory to market can take anywhere between<br />

10 to 20 years and will cost around US$1 billion.<br />

Fig 1 outlines a breakdown of the 2013 United<br />

States Food and Drug Administration (FDA)<br />

Investigational New Drug Application (IND) filing<br />

fees, estimated costs for each FDA approval phase<br />

and the likelihood of advancement between<br />

phases. As can be seen, most of the money is<br />

spent during the drug discovery and pre-clinical<br />

phases, with only five out of initially 5,000-10,000<br />

screened compounds advancing into clinical trials,<br />

of which only one may eventually be approved.<br />

The initial discovery and development phase can<br />

take anywhere between three to six years while<br />

the majority of time is taken up by clinical trials<br />

(six to seven years), before submitting a New<br />

Drug Application (NDA) to the FDA (Fig 2). Overall,<br />

the drug development process can be divided into<br />

five steps 1 .<br />

suitable molecules. Discoveries can also be made<br />

when an existing treatment shows unexpected<br />

effects. For example, patients on bimatoprost<br />

(Lumigan) eye drops, a prostaglandin analogue<br />

used in the treatment of open-angle glaucoma<br />

and approved by the FDA in 2001, experienced<br />

growth of longer, thicker and darker eye lashes<br />

resulting in the approval of Latisse for cosmetic<br />

purposes in 2008. Repurposing of an already<br />

existing drug with proven safety is also generally<br />

much faster and less costly.<br />

While thousands of compounds may be potential<br />

candidates for drug development, only a small<br />

number actually proceed to preclinical studies.<br />

Thus, once a promising candidate has been<br />

identified, further experiments are performed<br />

to elucidate the drug pharmacokinetics, the<br />

exact mechanism of action, the best dose and<br />

route for administration as well as any potential<br />

adverse effects. Only if there is no toxicity and the<br />

candidate shows clear advantages over current<br />

drugs on the market, ie. a different mechanism of<br />

action, less adverse effects or less frequent dosing,<br />

should it proceed into preclinical studies.<br />

Fig 1. Estimated non-capitalised costs for new drug development and advancement between FDA approval phases 2<br />

(cell culture) and in vivo (animal) studies. Such<br />

studies must be performed under good laboratory<br />

practice (GLP) guidelines, setting minimum<br />

requirements for personnel, equipment,<br />

protocols, operating procedures, reports and<br />

quality assurance. Pre-clinical studies are<br />

generally small with often only six replicates per<br />

treatment group. However, they must still provide<br />

sufficient detail on dosing and toxicity before the<br />

candidate can move into clinical trials.<br />

One of the greatest challenges for translation<br />

of a drug from the laboratory bench into humans<br />

remains the poor correlation of pre-clinical<br />

data with clinical trial results often due to the<br />

different anatomy and physiology of most animal<br />

eyes. Moreover, the majority of animal disease<br />

models are acute and very homogenous while<br />

the human condition is often chronic and can<br />

vary significantly between patients. It is therefore<br />

no surprise that a number of molecules having<br />

shown great efficacy in animal studies end up<br />

failing in clinical trials.<br />

Step 3 – Clinical research<br />

Drug is tested in humans to prove safety and<br />

efficacy<br />

While pre-clinical research can answer basic<br />

questions about a drug’s safety and efficacy,<br />

it is not a substitute for studying the drug’s<br />

interactions with the human body. However,<br />

before being allowed to start clinical trials, an<br />

IND has to be submitted, including animal study<br />

and toxicity data, manufacturing information,<br />

clinical trial design, data from any prior human<br />

research and information about the investigator.<br />

The FDA then has 30 days to review and respond<br />

to the IND submission. Clinical trials are designed<br />

to answer specific research questions related to<br />

the new drug and a number of critical aspects<br />

such as patient selection criteria, participant<br />

numbers, study duration, data to be collected and<br />

how these will be analysed, need to be carefully<br />

considered. Typically, clinical trials follow a series<br />

from early, small-scale, Phase I studies to latestage,<br />

large scale, Phase III studies followed by<br />

even larger Phase IV trials after market approval<br />

(Table 1).<br />

impossible to have complete information about the<br />

drug’s safety at the time of approval. Despite the<br />

rigorous steps taken during the drug development<br />

process, limitations exist. Therefore, the true picture<br />

of a product’s safety generally evolves over months<br />

and even years after marketing. The FDA reviews<br />

any problem reports and can decide to add cautions<br />

to the usage information or even withdraw the<br />

product in case of more serious issues.<br />

Generic drugs, new drug delivery systems<br />

and natural health products<br />

Newly approved drugs are generally patent<br />

protected which means only the sponsor has<br />

the right to market the drug. However, once<br />

the patent expires – typically 20 years from<br />

the earliest application filing date – other<br />

drug manufacturers can develop a generic<br />

version, which must have the same dosage<br />

form, strength, safety, quality, performance<br />

and intended use. If all of these are adhered to,<br />

generic drug manufacturers only have to perform<br />

bioequivalence studies instead of conducting<br />

lengthy and costly clinical trials.<br />

Already approved drugs may also be combined<br />

with a new delivery system such as a sustained<br />

release system, as is the case for the Ozurdex<br />

dexamethasone implant. However, although<br />

safety and efficacy of the incorporated drug have<br />

already been demonstrated in numerous clinical<br />

trials, the combination product is considered a<br />

new entity and an additional IND has to be filed<br />

before conducting further clinical trials. These<br />

may be less extensive, but still mean many years<br />

of development and additional costs, thus only<br />

combination products that show clear advantages<br />

over already approved formulations should be<br />

further investigated.<br />

In comparison to many other countries, natural<br />

health products are currently unregulated in New<br />

Zealand. While the Government and the Green<br />

Party announced plans to develop a regulatory<br />

scheme for natural health products to reduce risks<br />

associated with unsafe ingredients, uncontrolled<br />

health claims and poor manufacturing in 2009,<br />

the Natural Health Products Bill has not been<br />

reinstated by the new government so far.<br />

I<br />

Fig 2. Drug research and development process (IND: Investigational New Drug Application; NDA: New Drug Application; BLA: Biologics License<br />

Application) 3 Table 1. Clinical trial phase overview 1<br />

Step 1 – Discovery and development<br />

Research for a new drug begins in the laboratory<br />

Novel drugs are often discovered after new<br />

insights into a disease process have been gained<br />

allowing the researcher to design or screen for<br />

Step 2 – Preclinical research<br />

Drug undergoes laboratory and animal testing<br />

Before advancing to clinical trials, researchers<br />

must confirm there is no potential for the new<br />

molecule to cause serious harm using in vitro<br />

New OCT algorithm<br />

A<br />

new<br />

technique for identifying and<br />

diagnosing damage to the human retina<br />

has been awarded ‘Best Student Paper’ at<br />

the Bioimaging <strong>2018</strong> conference in Portugal.<br />

Doctoral candidate Bashir Dodo, from Brunel<br />

University London’s Department of Computer<br />

Science, demonstrated a new algorithm<br />

for optical coherence tomography (OCT)<br />

equipment which<br />

can automatically<br />

segment images of<br />

the retina into seven<br />

distinct layers.<br />

Whilst<br />

ophthalmologists<br />

are currently able<br />

to identify the<br />

layers manually<br />

from OCT images,<br />

Bashir Dodo<br />

Bashir’s algorithm automatically segments<br />

images of the retina, allowing specialists to<br />

spot abnormalities quicker and better track the<br />

progress of medication, he said. He hopes the<br />

new technique will improve accuracy and speed<br />

of diagnosis to help save sight by identifying<br />

problems earlier. “Automatically segmenting<br />

the layers could provide critical information<br />

for abnormality detection by comparing them<br />

to the average population and monitoring the<br />

progress of disease against previous scans.”<br />

II<br />

III<br />

IV<br />

Step 4 – FDA review<br />

Thorough examination of all submitted data<br />

If pre-clinical and clinical research has shown a<br />

drug is safe and effective for its intended use,<br />

an NDA is submitted to the FDA, whose review<br />

team thoroughly examines all the submitted<br />

data before making a decision. The NDA has<br />

to contain everything about the drug, from<br />

preclinical data to Phase III trial results, as well<br />

as information required for marketing such as<br />

the proposed labelling and directions of use. If<br />

the application is deemed complete during the<br />

initial screening, the FDA has six to 10 months<br />

to make a decision on whether to approve the<br />

drug. In most cases, however, remaining issues<br />

such as addressing specific questions based on<br />

existing data or providing additional data, need<br />

to be addressed before a drug can be approved. A<br />

recent example in the ophthalmic field includes<br />

the rejection of Dextenza (Ocular Therapeutix),<br />

an intracanalicular dexamethasone insert<br />

intended for the treatment of ocular pain and<br />

inflammation following ophthalmic surgery, due<br />

to deficiencies in manufacturing processes and<br />

analytical testing. However, the company aims<br />

to re-file the NDA in <strong>2018</strong> after addressing the<br />

raised concerns.<br />

Step 5 – Post-market safety monitoring<br />

FDA monitoring of drug safety once available to<br />

the public<br />

Although clinical trials provide important<br />

information on a drug’s efficacy and safety, it is<br />

Final remarks<br />

Looking at FDA approval numbers between 2012<br />

and 2017 (584 in total), ophthalmic products only<br />

made up a very small percentage (


Meet the … research charity<br />

chairman<br />

Cure Kids has invested millions of dollars in child health research over the past 45<br />

years, including many projects relating to eye health, so we sent Jai Breitnauer to<br />

meet executive chairman Roy Austin to find out what keeps this charity giving.<br />

Most of the media seemed to be celebrating<br />

John Key’s knighthood in last year’s Queen’s<br />

Birthday Honours list, but among the<br />

usual politicians and political party donators were<br />

a number of worthy names, not least Roy Austin. A<br />

quiet, unassuming financier and chairman of the<br />

independent children’s medical research funding<br />

organisation Cure Kids, Austin was awarded the<br />

Companion of the New Zealand Order of Merit<br />

(CNZM) for services to children’s health and the<br />

community.<br />

“I’m humbled by the honour but, in my view, this<br />

is recognition for the teams I’ve worked with,” he<br />

said, when I met him in downtown Auckland for an<br />

early-morning coffee. “I have enormous admiration<br />

for all those who have contributed to children’s<br />

health research. The staff, the board members,<br />

the researchers and professors, the corporates and<br />

philanthropists who back us, the mums and dads and<br />

the kids themselves. The kids are the real heroes here.”<br />

Austin has been involved with Cure Kids since 1994,<br />

chairman since 1996 and executive chairman since<br />

2006, but admits he’s been involved in community<br />

projects most of his adult life.<br />

“I’ve always been heavily involved in local projects.<br />

My children went to the same schools I went to – my<br />

grandchildren are there now. I sat on the boards and<br />

helped raise money for the local area.”<br />

Austin was born in Christchurch but moved to<br />

Auckland’s Eastern suburbs at age six. Apart from a short<br />

period living in Berlin, he has lived in Kohimarama for<br />

most of his life.<br />

As well as taking an active part in his kids’ school<br />

community, he was also involved in the Rotary Club of<br />

Remuera and was part of the team supporting paraathlete<br />

neuroscientist, Dr William Tan, who was paralysed<br />

by polio at age two, on his infamous North Island<br />

wheelchair marathon to raise money and awareness for<br />

diabetes research.<br />

“My elder daughter had been diagnosed with Type 1<br />

diabetes, so it was important to me personally,” explains<br />

Austin. “It was a great experience. The Rotary Club<br />

eventually raised over a million dollars. So, when I was<br />

asked to join the board of the National Children’s Health<br />

Research Foundation in 1994, I didn’t think twice.”<br />

Embracing change<br />

Originally founded by Rotary in 1971, today the<br />

Foundation is better known as Cure Kids, a name change<br />

implemented by Austin and other board members in<br />

2006. Austin admits he had been quietly instigating<br />

other changes in the organisation since he took over as<br />

chairman in 1996. When he joined the board, he says,<br />

he felt there had to be a better way to fundraise than to<br />

simply rely on public donations.<br />

“We set up four paediatric health chairs at three<br />

universities: one in Otago, one in Christchurch and two<br />

in Auckland.” This was done in partnership with the<br />

universities, explains Austin. “Similar to an endowment<br />

policy, a lump sum provided by Cure Kids was invested<br />

to provide a steady income for research in the future. It<br />

made sense for the universities to match this funding as<br />

it secured an annual investment into research, and the<br />

brilliant academics could focus on their work instead of<br />

worrying about being funded the next year.”<br />

Despite this success, public donations still couldn’t keep<br />

up with demand for research grants in other areas and<br />

Austin realised more change was needed.<br />

“Leverage, leverage, leverage. All my thinking was<br />

directed by that,” he says. “For every dollar we got, I asked<br />

how could we double it for research? I realised we had<br />

a key asset that no one had looked into and that was<br />

intellectual property (IP).”<br />

In the early-1990s, the National Children’s Health<br />

Research Foundation had undertaken a little-known piece<br />

of research that identified the A1 type of beta casein<br />

predominantly found in cow’s milk and found it may be<br />

Cure Kids executive chairman Roy Austin CNZM<br />

a risk factor for heart disease and was linked to insulin<br />

dependent diabetes in children. Less common A2 milk did<br />

not carry these apparent risks.<br />

“A well-known businessman approached us to sell<br />

that IP to him,” says Austin. “The sale eventually raised a<br />

significant amount for Cure Kids – millions of dollars – and<br />

changed our thinking around fundraising.”<br />

Cure Kids entered into IP partnership agreements<br />

with the universities undertaking Cure Kids investment<br />

research, allowing the organisation to leverage its value to<br />

fund further research.<br />

The business of research<br />

When the government established the New Zealand Seed<br />

Co-investment Fund in 2006 (SCIF), Cure Kids applied to<br />

become a partner, creating a seed co-investment capital<br />

fund worth $8 million under the umbrella of Cure Kids<br />

Ventures and funded by the A2 milk IP sale. To date, the<br />

fund has invested in eight different companies focused on<br />

child health research potential breakthroughs from asthma<br />

medication compliance to growing a child’s own skin cells<br />

for grafts.<br />

This strategy was not without criticism.<br />

“People asked me, ‘is it really the place of a charity to<br />

invest in business?’” says Austin. “But this model enables<br />

us to access new sources of commercial funding for<br />

investment via financial partners. Investment is not a dirty<br />

word. You are still investing into child health research,<br />

and under a corporate structure there is greater access to<br />

investment funds.”<br />

Under Austin’s leadership, Cure Kids has become one of<br />

the largest funders of child health research in New Zealand.<br />

In the optics field in 2016, the Cure Kids Innovation Seed<br />

Fund invested in Professor Steven Dakin’s research into<br />

autism spectrum disorder and eye movements at the<br />

School of Optometry and Vision Science at the University of<br />

Auckland. Professor Dakin also received two seed grants in<br />

2014 for his work around amblyopia.<br />

The real focus is always the children; the kids who suffer<br />

from the many conditions Cure Kids-funded research is<br />

aiming to help, says Austin. “These children remind us<br />

constantly of the important work we are funding and their<br />

strength keeps us going. I just feel so blessed to have been<br />

involved for the last 23 years. You see some of these kids<br />

and you think, ‘wow’.<br />

They deserve a healthy<br />

life and it’s our job to<br />

make it happen.” ▀<br />

Focus on<br />

Eye Research<br />

Glaucoma and IOP, Xen and<br />

nocturnal blood pressure<br />

EFFICACY, SAFETY AND RISK FACTORS<br />

FOR FAILURE OF XEN GEL MICROSTENT<br />

IMPLANTATION VERSUS STANDALONE<br />

TRABECULECTOMY<br />

Schlenker MB, Gulamhusein H, Hengerer<br />

IC et al<br />

Ophthalmology 2017;124:1579-1588<br />

The Xen gel stent is a new procedure that<br />

has recently become available in New<br />

Zealand and is considered an alternative<br />

option to trabeculectomy. The purpose<br />

of this study was to evaluate the efficacy,<br />

safety and risk factors for failure of Xen<br />

versus trabeculectomy. An international<br />

multicentre retrospective interventional<br />

cohort study was performed. Patients had<br />

open angle glaucoma and uncontrolled IOP<br />

despite maximum medical therapy, and no<br />

previous surgery.<br />

There were 354 eyes of 293 patients<br />

included in the study. The primary outcome<br />

measure was the failure rate between<br />

the two groups – defined as an IOP of 17 mmHg without glaucoma<br />

medication at least one month after<br />

surgery. The study also looked at ‘qualified<br />

success’ defined as an IOP between 6 and<br />

21 mmHg with medication.<br />

No significant difference in failure rate<br />

between the two procedures was identified<br />

(Hazards ratio 1.2, 95% CI 0.7-2.0). This was<br />

also the case for qualified success (HR 1.3,<br />

CI 0.6-2.8). The time to 25% failure was<br />

also not significantly different between<br />

the groups. Diabetes was the only factor<br />

significantly associated with failure, while<br />

Caucasian ethnicity was associated with<br />

a decreased risk of failure. Complications<br />

were mostly transient, occuring in 9% of<br />

Xen and 16% of trab patients. Post op.<br />

interventions such as bleb needling were<br />

common, occuring in 43% of Xen and 31%<br />

of trab patients.<br />

Comment: The proposed advantages of<br />

Xen include reduced surgical time, reduced<br />

risk of complications and more rapid<br />

visual recovery. This study suggests both<br />

procedures are similar in their efficacy over<br />

the duration of this study and the safety<br />

profile is also similar although there was<br />

a slightly lower rate of complications for<br />

Xen. Further randomised clinical trials<br />

are, however, needed as well as studies<br />

to evaluate the cost-effectiveness of Xen<br />

versus trabeculectomy.<br />

For more about Xen in practice see the<br />

December issue of NZ Optics.<br />

GLAUCOMATOUS OPTIC NEUROPATHY<br />

ASSOCIATED WITH NOCTURNAL DIP IN<br />

BLOOD PRESSURE<br />

Melgarejo JD, Lee HJ, Petitto M, et al<br />

Ophthalmology <strong>2018</strong> (in press)<br />

The purpose of this study was to determine<br />

if noctural blood pressure (BP) is associated<br />

with an increased risk of glaucoma. An<br />

observational cross-sectional study was<br />

performed involving a subset of participants<br />

from the Maracaibo Aging Study. These<br />

participants had to be at least 40 years of<br />

age, and had measurements including OCT,<br />

visual field (VF) testing, IOP 20% compared to daytime BP)<br />

in night time systolic and diastolic BP was<br />

identified as the significant risk factor for<br />

glaucomatous damage (odds ratio 19.8 and<br />

5.5 respectively).<br />

Hence the results of this study suggest that<br />

the link between nocturnal BP and GON is<br />

due to extreme dipping in BP rather than<br />

low nocturnal BP levels alone.<br />

Comment: The results of this study support<br />

the hypothesis that significant nocturnal<br />

dips in BP are a risk factor for glaucoma.<br />

Hence individuals at risk of nocturnal dips<br />

in BP do need to be assessed and monitored<br />

for glaucoma. Timing of antihypertensive<br />

intake to avoid nocturnal dips would also<br />

be advised. Patients already diagnosed with<br />

normal-tension glaucoma and who are<br />

progressing, may need to undergo 24-hour<br />

BP monitoring to determine if nocturnal<br />

dips in BP is a contributing factor.<br />

VARIATION IN IOP AND THE RISK OF<br />

DEVELOPING OAG: THE LOS ANGELES<br />

LATINO EYE STUDY<br />

Jiang X, Torres M, Varma R<br />

American Journal of Ophthalmology <strong>2018</strong><br />

(in Press)<br />

The purpose of this study was to determine<br />

whether measures of intraocular pressure<br />

(IOP) variation are independently<br />

associated with the risk of developing<br />

open angle glaucoma (OAG). This was part<br />

of a population-based, longitudinal study<br />

involving 3666 individuals with no history<br />

of OAG at baseline and followed up four<br />

years later.<br />

Maximum IOP, standard deviation (SD)<br />

of IOP, range of IOP and mean IOP were<br />

derived from participants after taking<br />

several measurements at multiple visits.<br />

OAG diagnosis was based on the consensus<br />

of experts who had access to all clinical<br />

examination data (including stereoscopic<br />

fundus images and visual field testing).<br />

Multivariate logistic regression analysis was<br />

also performed.<br />

The incidence of OAG occurred in 73 study<br />

participants over the four years. The three<br />

measures of IOP variation (maximum IOP,<br />

SD and range of IOP) were all identified to<br />

be independently associated with the risk of<br />

developing OAG. This was still the case when<br />

participants were separated into those with<br />

a mean IOP of less than 15 mmHg and those<br />

with 15 mmHg or higher. Mean IOP was<br />

associated with OAG risk only in those with<br />

higher IOPs and not in those with lower IOPs.<br />

Maximum IOP was identified to be the most<br />

significant predictor of OAG.<br />

Comment: This study suggests that<br />

variations in IOP and in particular<br />

maximum IOP are damaging to the optic<br />

nerve and are independent risk factors<br />

for glaucoma. This highlights the value of<br />

measuring IOP variation (with day phasing<br />

or the water drinking test) as part of the<br />

work up of glaucoma suspects. This may<br />

also be useful in patients with glaucoma<br />

progression as it is likely IOP variation also<br />

plays a role here. ▀<br />

ABOUT THE AUTHOR:<br />

*Dr Hussain Patel specialises in glaucoma and cataract<br />

surgery and is a consultant ophthalmologist at<br />

Greenlane Clinical Centre, Auckland District Health<br />

Board and a<br />

senior lecturer in<br />

ophthalmology at<br />

the University of<br />

Auckland. He also<br />

works in private<br />

practice at Eye<br />

Surgery Associates,<br />

Auckland, and<br />

Hamilton Eye<br />

Clinic.<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

17


Myths, mysteries and eye protection<br />

BY ANNETTE HOSKIN*<br />

If you had to choose to keep one of your five<br />

senses, which one would it be? A recent survey<br />

found most people indicated their vision was<br />

the most valuable of their senses. Despite this,<br />

eye injuries are still a common occurrence with<br />

more than 55 million people suffering a potentially<br />

vision threatening eye injury every year. Yet 90%<br />

of these injuries are preventable with the right<br />

eye protection. Eye injuries represent a significant<br />

burden not only to the individual, but also to<br />

industry and the community.<br />

A review from Waikato Hospital (Pandita,<br />

2012) found young males at work or outdoors<br />

had the highest risk of eye injuries. Work-related<br />

equipment was found to be a major contributor<br />

including lawn moving, farm fencing, hammering,<br />

chain sawing, tree pruning and grinding. While<br />

sodium hydroxide and sodium hypochlorite were<br />

responsible for several eye injuries in the study.<br />

Both are commonly used chemicals in oil refining,<br />

hydraulic fracturing, water treatment, metal<br />

processing and in cleaning agents such as oven<br />

and drain cleaner.<br />

Eye injuries at work<br />

Eye injuries in the workplace come at a high<br />

cost, not only for workers but also the employer,<br />

the community and the injured person’s family.<br />

Workplace-related injuries are a common cause<br />

of lost days at work, reduced productivity and<br />

medical and workers’ compensation costs.<br />

Many occupations are particularly high risk for<br />

eye injuries, including mining, manufacturing,<br />

construction, agriculture, forestry and fishing.<br />

Injuries commonly occur when operating<br />

mechanical equipment which can generate<br />

foreign bodies traveling at high speed that become<br />

embedded in the eye. Chemical splashes and spills<br />

as well as radiation sources are also common<br />

hazards.<br />

But work’s not the only problem<br />

An increasing number of eye injuries occur at<br />

home and on the weekends while playing sports<br />

or doing DIY. Everyone needs to ensure they are<br />

protected from hazards around the home, such<br />

as cleaning chemicals and high-speed particles<br />

from machinery. It’s also important to ensure<br />

children are protected from these hazards – don’t<br />

let children near machinery such as whipper<br />

snippers and lawnmowers, for example, because<br />

of the potential for stones and other sharp objects<br />

to be thrown up. Sports with bats and balls such<br />

as tennis, squash and cricket are commonly<br />

associated with eye injuries and could be<br />

prevented by the right eye protection.<br />

What type of eye protection is best?<br />

Different environments and tasks require different<br />

types of personal protective equipment (PPE)<br />

and eye protection is no exception. Ensuring eye<br />

protection meets the individual needs of each<br />

wearer is essential. Not surprisingly, eye injuries<br />

can still occur if people are wearing the wrong type<br />

or fit of eye protection. Choice is critical to ensure<br />

adequate eye protection and optimal vision to<br />

suit the needs of the individual in their activities.<br />

<strong>2018</strong><br />

SAVE THE DATE<br />

EDITION <strong>2018</strong><br />

28 TH SEPTEMBER-1 ST OCTOBER<br />

18 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong><br />

silmoparis.com<br />

Optometrists and optical<br />

dispensers can play a key<br />

role in advising on the best<br />

type of eye protection.<br />

In this part of the world,<br />

eye protection must meet<br />

the Australian New Zealand<br />

Standard AS/NZS1337.1,<br />

and for most hazards,<br />

medium-impact protection<br />

is a good choice for all<br />

round protection. People<br />

requiring a prescription<br />

for good vision can also<br />

purchase the right type of<br />

eye protection, with eye<br />

protection made specific<br />

to their prescription and<br />

meeting the prescription<br />

standard (AS/NZS1337.6).<br />

Employees should be<br />

shown how to fit and<br />

use their PPE correctly as<br />

well. Table 1. is an excerpt<br />

from AS/NZS1336 that<br />

provides a summary of<br />

some eye hazards and the<br />

appropriate eye protection<br />

choices*. Where mediumimpact<br />

protection is<br />

specified, eye protectors<br />

will incorporate lateral<br />

protection into the frame<br />

or lenses or permanently attached side shields. Fit<br />

and coverage is critical and should be checked to<br />

ensure adequate level of protection from hazards.<br />

Good vision for safety<br />

For patients requiring spectacle correction, many<br />

options are available. The best option for vision, fit,<br />

comfort and coverage is custom-made prescription<br />

eye protection that complies with AS1337.6.<br />

Vision plays a critical role in every part of our lives.<br />

Studies have shown people with uncorrected or<br />

reduced vision are more than 60% more likely<br />

to have an occupational injury. With the aging<br />

workforce, it is important to ensure their distance<br />

and near visual needs are met with the best<br />

prescription eye protection.<br />

Contact lenses can be worn in most<br />

circumstances when accompanied by the<br />

appropriate eye protection, but should never<br />

be considered as a form of eye protection. In<br />

some industrial situations, such as when dust or<br />

harmful liquids or gases are present, there may<br />

be additional consequences if eye protection fails<br />

when contact lenses are worn.<br />

Do I need certified eye protection?<br />

Certified eye protection provides the best<br />

guarantee of protection. Certified products are<br />

regularly tested for optical, transmittance and<br />

impact qualities with manufacturing of the<br />

frames, lenses and complete products regularly<br />

audited to ensure protective characteristics and<br />

quality are maintained.<br />

Can I wear my regular specs or sunnies?<br />

Ordinary sunglasses or regular spectacles are<br />

not the correct or recommended<br />

eyewear in places where hazards<br />

exist, not just because they don’t<br />

protect your eyes but also because of<br />

the potential added hazard from the<br />

lenses breaking. Eye protection can,<br />

however, also provide protection from<br />

ultraviolet (UV), so sunglasses can’t<br />

be eye protectors but eye protectors<br />

can be sunglasses.<br />

The importance of UV<br />

protection<br />

With some of the highest rates of sun<br />

cancer in the world, when spending<br />

long hours in the New Zealand sun,<br />

protection from UV light is critical.<br />

Exposure to the sun’s UV rays has<br />

been linked to cataracts, macular<br />

degeneration, pinguecula, pterygia<br />

and photokeratitis. Outdoors workers<br />

should be encouraged to slip, slop,<br />

slap and slide on a pair of eye<br />

protection goggles, which incorporate<br />

UV and glare protection.<br />

What you can do!<br />

Optometrists, ophthalmologists,<br />

orthoptists and dispensers play<br />

an important role in preventing<br />

eye injuries. By understanding the<br />

potential hazards their patients<br />

may be exposed to, both at work<br />

The right eye protection for work and life is critical to reducing eye injuries<br />

and during recreation and leisure time, they can<br />

prescribe the right level of eye protection. When<br />

dispensing eye protection, it is critical to ensure<br />

the frame and lens provide adequate protection<br />

and the gaps between the frame and the face are<br />

minimised. A comfortable and secure fit will help<br />

ensure protection and compliance with the eye<br />

protection programme.<br />

Activity or Process Hazard Possible methods<br />

of control<br />

Manual chipping,<br />

hammering, riveting<br />

Machine cutting,<br />

grinding of metals<br />

Flying fragments, low<br />

velocity, low mass<br />

Small particles with<br />

medium to high<br />

velocity<br />

Regular eye examinations provide the perfect<br />

opportunity to assess the adequateness of eye<br />

protection. Individuals should be encouraged to<br />

bring all their glasses when attending an eye exam<br />

so practitioners can inspect their eye protection<br />

as well as their regular spectacles. With age and<br />

accidental damage, eye protectors can deteriorate.<br />

Air-born chemicals and commonly used substances<br />

such as sunscreen, can damage the frame and<br />

lenses. It is generally recommended that eye<br />

protectors be replaced every two years unless<br />

evaluated as satisfactory for continued use.<br />

Eye protection represents a great opportunity<br />

to increase your primary health care role with<br />

patients and work more closely with industry to<br />

promote eye injury prevention. When discussing<br />

patients visual needs, it’s a great opening to<br />

understand the hazards they may be exposed to at<br />

work, during their leisure time and at home, and<br />

promote the need for correct eye protection.<br />

*To purchase a copy of the full standard, please go<br />

to http://infostore.saiglobal.com/store/<br />

Fixed or mobile<br />

screens<br />

Fixed or mobile<br />

screens, dust<br />

extractors<br />

Suitable eye protection<br />

Low-impact eye protection<br />

Medium-impact eye<br />

protectors, etched with an<br />

“I” or “F”. High-impact face<br />

shields, etched with a “V”<br />

Outdoor workers Ultraviolet light Shade structures Tinted or outdoor untinted,<br />

etched with “O”<br />

Horticulture and<br />

gardening, including<br />

lawn mowing, wiper<br />

snipper’s, edger’s<br />

NB. Both user and<br />

spectators are at risk<br />

Chemical processes<br />

eg. spray painting<br />

Chemical processes<br />

eg. cleaning solutions<br />

incorporating alkali<br />

Medical and<br />

veterinary hazards<br />

Laser based surgical<br />

and cosmetic<br />

procedures e.g. laser<br />

hair removal<br />

Non-ionizing radiation<br />

eg. welding, furnace<br />

work<br />

Flying fragments, high<br />

velocity, low mass.<br />

Sunglare<br />

Guards on equipment<br />

Medium-impact eye<br />

protectors, etched with an<br />

“I” or “F”.<br />

High-impact face shields,<br />

etched with a “V”. Tinted or<br />

outdoor untinted, etched<br />

with “O”<br />

Gases, vapours Exhaust systems Gas-resistant goggles,<br />

etched with “G”<br />

Liquid splashes Splashguards Splash resistant goggles,<br />

etched with “C”. Face<br />

shields (used in addition to<br />

goggles)<br />

Biological splash,<br />

droplet infection, direct<br />

contamination<br />

Optical and thermal<br />

hazards<br />

Non-ionizing radiation<br />

Table 1. A summary of eye hazards and appropriate eye protection<br />

Administrative<br />

controls and physical<br />

barriers<br />

Physical barriers<br />

Welding screens<br />

complying with AS/<br />

NZS3597<br />

Splash resistant (indirectly<br />

vented) goggles, etched<br />

with “C”. Face shields (used<br />

in addition to goggles)<br />

Refer to AS1337.4 (10) and<br />

AS1337.5(11)<br />

Refer to AS/NZS1338 .1(12)<br />

and AS/NZS1338.2(13) or<br />

AS/NZS1338.3(14)<br />

About the author<br />

*Annette Hoskin is an optometrist,<br />

commercial scientist and researcher<br />

based in Perth, with a special interest<br />

in safety innovation and compliance<br />

standards for eyewear. She’s Optometry<br />

Australia’s representative on Standard<br />

Australia’s eye protection committee<br />

and sits on the International<br />

Organisation for Standardization<br />

Annette Hoskin<br />

(ISO) committees TC94 and 172. She is<br />

working towards a PhD on the incidence<br />

and epidemiology of eye injury prevention with the Save Sight<br />

Institute and the Lions Eye Institute at the University of Western<br />

Australia and is research and development manager with Shamir<br />

Australia. She was also recently awarded a NHMRC Public Health<br />

Dora Lush Postgraduate Scholarship to further her work in <strong>2018</strong>.


Cutting it in today’s optical retail world<br />

BY JUANITA NEVILLE-TE RITO*<br />

As both retailers and customers, I think many<br />

of us recognise there has been a significant<br />

upheaval in the world of retail over the past<br />

decade.<br />

Retail is cut-throat. Our mobile-first shoppers can<br />

access anything with a swipe, click or Google to<br />

help guide their decisions and choices. So, retail is<br />

no longer one-dimensional. It’s now comprised of<br />

a whole ecosystem of virtual, digital, physical and<br />

social expressions about your offerings.<br />

Amongst all this noise and chaos, today’s<br />

consumers do not buy just products and services<br />

anymore. Their purchase decisions now revolve far<br />

more around buying into an idea and an experience.<br />

Shoppers can be irrational and unpredictable,<br />

but they do crave rich, seamless, engaging and<br />

frictionless experiences. They want to touch, feel,<br />

taste, smell and interact with what they are buying<br />

or who they are buying from. They want to engage,<br />

and be engaged, at a personal level.<br />

Optical retailing is a category which, in<br />

some quarters, has lost its mojo. But in others,<br />

evolving optical retailers are cleverly adapting<br />

their businesses to connect with their shopper’s<br />

hearts, imaginations and their wallets. They have<br />

embraced today’s retail trends, maximizing their<br />

customers’ total retail experience, embracing social<br />

community, providing enriched experiences and<br />

clever personalisation tactics, all backed up by the<br />

latest technology and data.<br />

Here’s a few examples of those doing it well to<br />

illustrate what I mean.<br />

Kite: an eyewear boutique<br />

London’s Kite store has changed the way we look<br />

for eyewear and the typical experience of going to<br />

the optometrists. Born from both a love for fashion<br />

and eye care, and the desire to create a new breed<br />

of optometrists that delivers the best of both,<br />

Kite’s focus is on making a trip to the optometrist’s<br />

fun and pleasurable. As one retail magazine put it,<br />

more akin to shopping for new shoes, than visiting<br />

a healthcare provider.<br />

Kite has designed a cool, colourful boutique<br />

that fuses fashion, personal feel, good service and<br />

expert eye care into one in-store experience, that<br />

is both relaxed and professional. Staff project a<br />

friendly, non-pressure vibe. Walking through the<br />

doors, you feel less like a customer and more like a<br />

friend coming to hang out.<br />

The Kite kiosk is a multi-touch display which<br />

allows you to take #specselfies with your favourite<br />

Kite eyewear on and instantly share these with<br />

your friends and family on Facebook, Twitter<br />

and Instagram to see what they think. It’s just as<br />

refreshing as the carrot juice they offer on arrival.<br />

Different frame styles have been put into<br />

sections and all have their own unique postcard<br />

with their name and a brief description of the<br />

glasses, size and extensive number of colours<br />

available. Wave that postcard in front of Kite’s<br />

frame stylist and they will know exactly what<br />

you want. Plus, all the styles are displayed in both<br />

optical and sunglass versions.<br />

Kite: appealing to younger consumers<br />

Consumer trends for <strong>2018</strong><br />

BY SUSANNE BRADLEY<br />

Despite a strengthening global economy<br />

and consumer expenditure expected<br />

to grow at its strongest rate since<br />

2011, shifting consumer attitudes and<br />

behaviours, together with improved mobile<br />

technology and internet access, will continue<br />

to cause disruption for retail businesses in<br />

<strong>2018</strong>, says global market intelligence agency<br />

Euromonitor International.<br />

Its recently released report, the Top 10<br />

Global Consumer Trends for <strong>2018</strong>, identifies<br />

sharing and renting, not ownership, as a<br />

key trend, while ‘hashtag’ activism has led to<br />

unprecedent consumer power forcing businesses to<br />

re-think their branding and marketing strategies.<br />

Sharing services, particularly, are expected to<br />

soar in <strong>2018</strong>, says report author Alison Angus,<br />

Euromonitor’s head of lifestyles. One of the many<br />

examples of this is the still relatively new pay-as<br />

you-wear designer outfit rental service, Style Trial,<br />

offered by one London Westfield shopping centre.<br />

Meanwhile, in New Zealand, anyone living in or<br />

visiting Auckland this summer would have been<br />

hard pressed not to notice the new, privately-run<br />

Onzo bike sharing trial.<br />

The rise of augmented reality (AR), blending the<br />

digital world with the real world around us, is also<br />

expected to go mainstream in <strong>2018</strong>, increasingly<br />

affecting how consumers seek and shop for<br />

products. AR technology, now available on newer<br />

smartphones, allows consumers to virtually try<br />

products before buying online or in-store. And<br />

this is happening already, says Angus, naming the<br />

Sephora AR app, which lets people virtually test<br />

beauty products, and the Dulux Visualiser app,<br />

allowing you to see what your painted walls could<br />

Onzo bikes demonstrating our growing love of sharing<br />

AR blending the real and digital world<br />

look like, as examples.<br />

With AR, online shoppers will have a more<br />

realistic view of the item they are researching and<br />

may, consequently, be more likely to complete<br />

the purchase online, she says. She expects return<br />

rates for online businesses which offer AR tools<br />

to reduce as a result. Consumers will also actively<br />

begin to look for brands which have AR apps,<br />

she adds, so they can experience products, like<br />

eyewear better from the comfort of their own<br />

living rooms, sharing what they find and gaining<br />

feedback from their peers online.<br />

Another trend gaining in popularity, according<br />

to Angus, is on-demand solutions for our hectic<br />

and mobile lifestyles, with the take up of those<br />

solutions driven by our increasing desire to<br />

cut costs, save time and live more freely, while<br />

attempting to be as eco-friendly as possible.<br />

Our love of personalisation is continuing to<br />

push customisation to new levels. Companies<br />

like Converse and Nike, for example, now invite<br />

consumers to take part in the creative process.<br />

Understanding and thus communicating the<br />

journey of a product is also a growing trend so<br />

consumers are more likely to trust the brand<br />

and be more comfortable with the end result.<br />

While a new wave of companies aims to provide<br />

consumers with genetic findings related to their<br />

general health, fitness and nutrition.<br />

Euromonitor’s report doesn’t specifically advise<br />

what retailers should be doing to be successful in<br />

today’s demanding market but, reading between<br />

the lines, embracing technology, having a multichannel<br />

retail environment and giving consumers<br />

the opportunity to connect with your brand,<br />

and perhaps even influence the creative design<br />

process, should set you on the right path. ▀<br />

This is a game-changing<br />

experience creating a<br />

destination that draws<br />

people in, encourages them<br />

to linger longer and have fun<br />

with the products.<br />

Warby Parker: the total<br />

retail experience<br />

Total retail is retail that<br />

is delivered nimbly,<br />

seamlessly and holistically.<br />

An ecosystem delivering<br />

frictionless shopping<br />

experiences across many<br />

touchpoints. It is an<br />

elegant and engaging retail<br />

approach that makes a lot of<br />

money, often by employing<br />

an in-store experience built around the mobile<br />

and digitally-connected consumer. This panders<br />

to the tech-savvy’s consumer’s need to research<br />

online and purchase in-store, or “touch and feel”<br />

the merchandise in the store and then purchase<br />

online later.<br />

Warby Parker, embraces the total retail concept<br />

elegantly. It is a distinctive technology-based<br />

lifestyle brand that is becoming a major disruptor<br />

in the eyewear category. By designing and<br />

manufacturing their own frames and selling them<br />

directly to consumers, they’re able to charge as<br />

little as $95 per frame. A fraction of what a similar<br />

pair of glasses would cost at a competitor’s store,<br />

especially as the price includes prescription lenses,<br />

shipping and a donation to a not-for-profit.<br />

What makes Warby Parker stores remarkable is<br />

they break many of the traditional retail rules. The<br />

company sees its stores as giant advertisements<br />

to connect the Warby Parker brand with shoppers.<br />

This experiential hub is working, with the third best<br />

sales per square metre recorded internationally,<br />

lagging only behind Apple and Tiffany!<br />

At a Warby Parker store, you are greeted as you<br />

cross the threshold. Their staff recognise that if<br />

there isn’t a warm welcome, there may never be a<br />

customer journey. Warby Parker stores also have<br />

a “mirrored layout,” where every frame displayed<br />

on the left wall is also displayed on the right. This<br />

sacrifices close to 50% of the store’s prime space but<br />

keeps customers from having to jostle with each<br />

other to look at or try on a particular pair of frames.<br />

Toyshades: toying with you<br />

Founded in 2013, Toyshades offers a stylish<br />

simplicity to eyewear retailing and a new and<br />

innovative approach to product design and<br />

pricing. The company’s aim is “to create affordable<br />

Toyshades: a simple, direct approach<br />

For more<br />

personalised<br />

eye care, talk to<br />

Eye Surgery<br />

Associates<br />

SERVICES INCLUDE:<br />

• Cataract surgery specialists<br />

• Glaucoma<br />

• Medical & Surgical Retina<br />

• Acute & General Ophthalmology<br />

Clinics on the North Shore,<br />

Central and South Auckland<br />

Warby Parker: an elegant approach<br />

Phone 0800 750 750 or Fax 09 282 4148<br />

info@eyesurgeryassociates.co.nz<br />

www.eyesurgeryassociates.co.nz<br />

Eye Surgery Associates are a Southern Cross Health Society Affiliated Provider<br />

eyewear that is fashion-forward without the heavy<br />

price tag”. Its distribution model includes not only<br />

online, but concession stores in the likes of popular<br />

fashion retailer Topshop.<br />

By making the price accessible, Toyshades is<br />

making plano glasses a fashion accessory. You<br />

wouldn’t walk into an optometrists and think,<br />

‘today, I’m going to try on a pair of clear lens<br />

glasses even though I have perfect vision’. But in<br />

Topshop, it’s a no-brainer: you put them on, you<br />

look good, and they’re just £20.<br />

For those who do actually require prescription<br />

lenses in their new glasses, the BYOP (bring-yourown-prescription)<br />

service costs £40, and Toyshades<br />

claims it can have frames ready in just one hour.<br />

Setting the bar higher<br />

Smart, slick, international competitors are landing<br />

on our shores in droves and online shopping, social<br />

media, shopper savviness and the proliferation of<br />

choice means the bar has never been higher. And<br />

guess what? It is still going up.<br />

The retailers explored in this article are great<br />

examples that you don’t have to have a one-sizefits-all<br />

approach. By understanding your customer<br />

better, ensuring the user experience is seamless<br />

and having an authenticity and truth to your own<br />

business story, will make all the difference.<br />

Here are three things to explore in your own<br />

business to help evolve it into a compelling and<br />

relevant offer for your customers and potential<br />

customers:<br />

1) Be uncomplicated – Have a clear proposition<br />

and tell that story: Why should I choose you over<br />

every other retailer that operates in your category?<br />

2) Be distinctive – What makes you so special?<br />

If I can buy it somewhere else for cheaper, what<br />

else do you offer that means I should choose you<br />

(eg. curation, depth of range, best array of quality,<br />

more colours, exclusives, service)<br />

3) Get personal – Truly understand that a<br />

customer likes to feel individual and important.<br />

Treat them with respect and have a two-way<br />

conversation. Stop talking at them, instead talk<br />

with them.<br />

Our shopper’s world is shifting and changing<br />

at a pace that it never has before. With so much<br />

information and options being thrown at them, it<br />

will be the experiences that you leave them with<br />

which will make them come back again and again.<br />

You know that feeling. You’ve had it yourself. ▀<br />

* Juanita Neville-Te Rito is founder of The Retail Collective<br />

Dr Hussain Patel<br />

Ophthalmologist<br />

MBChB, MD, FRANZCO<br />

Dr Monika Pradhan<br />

Ophthalmologist<br />

MS, DOMS, FCPS, MRCOphth<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

19


Style-Eyes<br />

Change it up: the art of<br />

display<br />

Fashion update<br />

Translucent is the flavour of the month this month, alongside vibrantly coloured<br />

metals in the new season collections. Here’s our pick of the new releases:<br />

Face á Face<br />

This season’s Face á Face collection is inspired by the colour<br />

palettes of Paul Gauguin and Henri Matisse with vibrant greens,<br />

blues and reds. A new modern and feminine shape featured here<br />

is Boccawalk 2, combining matt finishes and transparencies to<br />

create an attractive look.<br />

Face á Face’s Lewit concept, originally inspired by jewellery, offers<br />

a new square shape in 100% stainless steel, as shown by Lewit 3<br />

pictured here. Gold features in the outer frame contrasting with<br />

cherry red, plum, flashy blue or sky blue. Distributed by MSO for<br />

Eyes Right Optical.<br />

BY CYNTHIA PIZZINI-MARTIN*<br />

Are you wondering why your inventory is<br />

not moving as fast as you like? Do you<br />

need suggestions on how to improve your<br />

sell through? Now is the perfect time of year<br />

to revamp your displays in order to bring your<br />

inventory back to life.<br />

The displaying of eyewear collections is one of<br />

the most important and, very often, the most<br />

overlooked part of optical retailing. With this<br />

in mind, here are a few methods I’ve used over<br />

the years to make current frame selections more<br />

attractive to customers.<br />

Shift and move<br />

The easiest way to make your displays look fresh<br />

from season to season is to shuffle your entire<br />

assortment. Have you always displayed that<br />

collection in the same corner? Change it up!<br />

Your repeat customers will get the feeling that<br />

you have a new assortment without you having<br />

to spend any money at all. This process is easy<br />

and will change the mood and look of your store<br />

instantly.<br />

Organise by colour, dark and light<br />

Most frames are available in a variety of colors.<br />

It will make your display look much more<br />

organised if you group the collection by style<br />

and then by colour. All frames of the same model<br />

should be displayed together. This makes it much<br />

easier for the customer and the salesperson to<br />

easily identify which colours are offered in that<br />

particular model.<br />

A good tip is to display your merchandise, your<br />

frames, from dark to light or light to dark. This<br />

is visually appealing to the eye and keeps your<br />

display looking clean and organised.<br />

Separate optical from sun<br />

Some optical retailers choose to display optical<br />

frames and sunglasses together by designer. The<br />

best way to accomplish a cohesive display would<br />

be to make sure you place all the optical frames<br />

on one shelf and display sunglass offerings on<br />

a different shelf. If you are using frame boards,<br />

display the optical frames (according to model<br />

and then colour) on one row and the sunglasses<br />

on a different row.<br />

Change up window displays<br />

Your shop front shows potential shoppers what<br />

you are all about. What you display should make<br />

people want to come inside for a closer look, to<br />

automatically warm to you and your practice.<br />

Try something different that is eye catching and<br />

interesting. Create a display that showcases<br />

the trend for the season. For example, for early<br />

<strong>2018</strong> you could showcase eyewear with mirrored<br />

lenses in a variety of colours. The pop of colour in<br />

the lenses will attract the eye and the frames can<br />

convey what the popular style is at the moment<br />

(aviator, round shapes, etc.). Remember a great<br />

display is only great the first time the customer<br />

sees it. It’s not so great when they see it again<br />

and again, for months at a time. Change your<br />

window display frequently and make sure your<br />

windows are always kept clean and orderly.<br />

Window displays are the first impression you<br />

make to the public.<br />

Go shopping<br />

Is there a collection that no longer sells like it<br />

used to? What are you waiting for? Phase it out<br />

and replace it with a fresh new brand that you’ve<br />

never tried before. Now is the time to bring in<br />

that collection that your customers keep asking<br />

for. Make plans to visit a good optical fair for new<br />

collection and display inspiration.<br />

Prop it up<br />

Using fun props<br />

to display frames<br />

brings character<br />

to any collection.<br />

Anything can be<br />

used to display<br />

your eyewear.<br />

Try stacking a few books and then placing a<br />

few frames on top. You can also invest in a few<br />

custom display stands that will really showcase<br />

those special pieces from your special collections.<br />

Showcase those add-ons<br />

Make fun displays to showcase those eyewear<br />

holders and lens cleaning kits that are usually<br />

overlooked. Create a display on your sales counter<br />

to remind your staff and the customer that these<br />

extras are available. Promoting and selling these<br />

extras will add precious dollars to your bottom line.<br />

Keep it clean<br />

Nothing is worse than trying on a pair of glasses<br />

with dirty and/or scratched demo lenses. Take<br />

a walk around your shop and do a check for<br />

scratched or damaged demo lenses. If any of the<br />

lenses are in really bad shape, consider making<br />

the investment and replacing with new scratch<br />

free plano lenses.<br />

Have fun with these suggestions. Look at<br />

it as a way to team build and have your staff<br />

come together to complete the task. It will get<br />

everyone’s creativity flowing. The sales staff<br />

will be re-energized about the items they sell<br />

everyday and the extra effort will translate into<br />

revenue in no time. ▀<br />

*Cynthia Pizzini-Martin<br />

is a retired luxury<br />

eyewear executive<br />

residing in South East<br />

Asia, who enjoys writing<br />

about all things optical<br />

and helping small<br />

businesses become<br />

bigger business with<br />

one on one consulting.<br />

For more, visit www.<br />

cpmretailconsulting.com<br />

Xavier Garcia<br />

Stars and their Eyes…<br />

Brian McKeever<br />

Brian McKeever, a Canadian cross-country<br />

skier and 10-time paralympic games<br />

gold medalist lives with the progressive<br />

macular condition, Stargardt’s disease.<br />

McKeever was diagnosed when he was 18<br />

and remembers clearly the day he found out.<br />

“The optometrist said, ‘It’s really strange, I<br />

can’t get your eyes any better with lenses’. I<br />

knew exactly what it was because my Dad and<br />

Aunt both have Stargardts.I was referred to<br />

an ophthalmologist and we did some blood<br />

tests and realised I was a carrier for the same<br />

dominant gene.”<br />

McKeever, who became the first Canadian<br />

athlete to be chosen for both the Paralymic<br />

and Olympic teams in 2010, says those first<br />

few weeks post-diagnosis were rough. “There was<br />

a period of grieving and then I quickly realised I<br />

could look at my Dad and Aunt as examples. He<br />

was a teacher at an elementary school for more<br />

than 30 years. Okay, he doesn’t drive, he rides his<br />

FLEYE<br />

FLEYE Copenhagen unveiled its new Spring/<br />

Summer <strong>2018</strong> Signature Collection at MIDO and the<br />

second part of its smørrebrød campaign dedicated to<br />

Scandinavian food culture, using the imaginative colours,<br />

textures, and layerings found in a classic Danish smørrebrød.<br />

Distributed by Tracey Dobson<br />

Morel – Koali<br />

Tom Ford<br />

Xavier Garcia launched its new acetate “Minimalist” male and<br />

female collection at Mido. The new collection features<br />

architectural and minimalist modern shapes in<br />

translucent single warm and cool popping colours.<br />

Model Elodie, pictured here, is available in a range of<br />

different colours and offers a strong yet feminine look<br />

with its rounded square design. Distributed by Cardinal Eyewear.<br />

The Tom Ford eyewear collection includes a huge range of<br />

styles for both men and women, including the classic, thick<br />

and chunky round eye for men available in dark havana,<br />

featured here, as well as several other colours. For those<br />

wanting a lighter frame, the unisex transparent crystal grey<br />

frame in acetate with nose bridge and temples in metal, is<br />

still noticeably Tom Ford, but with a twist. Distributed by<br />

Healy Optical Group.<br />

DVF by Diane von Furstenberg<br />

DVF by Diane von Furstenberg is a new<br />

brand joining the VSP Australia stable<br />

from February. Diane von Furstenberg<br />

founded her famous lifestyle brand in<br />

1972, which is now celebrated for its bold,<br />

colourful prints. The new eyewear collection DVF,<br />

with slight cat eye models DVF5097 and DVF5098 shown here, offers optical<br />

frames and sunglasses with beautiful and bold silhouettes in translucent<br />

colours creating a layered look. Distributed by VSP Australia.<br />

Morel Lunettes’ house brand<br />

Koali has launched new model,<br />

Natice, a thin, light frame made<br />

entirely of stainless steel. The front<br />

is enhanced by a stainless-steel shell extending slightly over the top to<br />

add a touch of originality. To make the frame ever lighter, the front and<br />

the shells are joined together with a nylon frame when the glasses are<br />

assembled. Natice is available in four shapes, sized M to L, and each<br />

shape is available in five colours. The shells are available in several<br />

different colours and styles. Distributed by MSO for Eyes Right Optical.<br />

For contact details for frame distributors, please see your <strong>2018</strong> OIG,<br />

also online at: http://www.nzoptics.co.nz/suppliers ▀<br />

bike everywhere, but it wasn’t as big of a deal as<br />

the initial knee-jerk reaction may have seemed.”<br />

At the time of going to press, Brian McKeever was<br />

targeting further success at his fifth Paralympic<br />

Winter Games in Pyeongchang. ▀<br />

20 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong>


Celebrating loyalty and friendship<br />

Long-serving Elegance in Eyewear and Euro Optics<br />

team members, Gary Edgar and Christian Mair,<br />

were celebrated recently on one balmy evening in<br />

the Viaduct in Auckland. Between them Edgar, territory<br />

manager, and Mair, operations manager, have clocked up<br />

an impressive 45 years of service, with Edgar celebrating<br />

25 years and Mair, 20.<br />

“We are very grateful to have Christian and Gary as part<br />

of our team for so many years,” says company managing<br />

director Carl Doherty. “They are very hard working, dedicated<br />

and loyal with a vast amount of knowledge. It has been and<br />

continues to be a pleasure to work with them.”<br />

Edgar points out that those celebrating this milestone<br />

(see picture), including Euro Optics’ now retired founders,<br />

Carl’s parents Annette and Regan Doherty, have<br />

contributed an impressive, combined 150 years of service<br />

to the New Zealand and Australian optical industry. “The<br />

Doherty family are great to work for, I guess we are now<br />

on terms like Aunty Annette, Regano and Carlos,” he<br />

laughs. ▀<br />

NZOSS: Future sight<br />

BY NICK LEE, NZOSS PRESIDENT<br />

Hello dear readers and welcome to my first column for NZOSS,<br />

the New Zealand Optometry Student Society for <strong>2018</strong>. It<br />

almost seems redundant to wish you a Happy New Year now<br />

that two months have passed, but to our readers starting back at<br />

University in February, Happy New Year. Hopefully you’ve had a good<br />

relaxing break.<br />

The NZOSS executive committee: William Tang, Menaga Manokaran, Alice Jackson, Andrew Kim, Gemma Ji,<br />

Marna Claassen, Aimee Aitken, Nick Lee, Simran Kaur Virk, Katarina Marcijasz and Nileesha Parbhu<br />

Celebrating long service: Carl Doherty, Annette and Regan Doherty, Gary Edgar, Christian Mair and Brent Doherty<br />

Since its inception in 2013, NZOSS has grown in leaps and bounds<br />

and is growing more and more each year. Serving as a networking<br />

platform for the next generation of optometrists both within the<br />

university and out into the wider community, NZOSS is very excited to<br />

continue this role and we have an exciting calendar of events in the<br />

works for this year.<br />

We are continuing our roster of the usual favourites, such as<br />

Orientation Camp, pub crawls and the annual Eye Ball, but are<br />

also planning more sporting and cultural activities, more<br />

networking community-based events and more seminars<br />

from leaders in our industry.<br />

Each year, a new executive team is announced. This<br />

year we are very fortunate to have many returning<br />

executives, plus a smattering of new faces to help build<br />

upon our previous experiences. With our eyes focused<br />

on the future, our main goals this year are to promote<br />

and boost the connections between our members, other<br />

health professionals on campus and, of course, the wider<br />

optometric community.<br />

The year ahead is already shaping up to be a good one and<br />

we will endeavour to keep you regularly updated with the<br />

happenings from<br />

NZOSS. If you have<br />

any suggestions,<br />

ideas or wish to<br />

contact us about<br />

any upcoming event<br />

opportunities, please<br />

contact us on nzoss.<br />

uoa@gmail.com<br />

Till next time. ▀<br />

Essilor expands NZ team<br />

Essilor has added four new people to its New<br />

Zealand team and is hoping to add a fifth in<br />

the next couple of months, following what<br />

it said has been a successful year for its Platinum<br />

Partner practices.<br />

New Zealand-qualified dispensing optician Amit<br />

Chaudhary and Mike Manolas, who completed<br />

a Diploma in Optometry in South Africa and has<br />

also worked in dispensing roles in New Zealand,<br />

have both joined Essilor NZ in its Auckland<br />

headquarters to assist with customer service,<br />

training and other initiatives offered to Platinum<br />

Partners. While Brigit Healey, previously with<br />

Essilor’s specialist Australian safety company PSG<br />

Eyewear, has joined the team to support Essilor’s<br />

growth in the safety market and be the New<br />

Zealand-based safety contact for all PSG enquiries.<br />

Essilor has also expanded its lab team to cope<br />

with the company’s growth last year, said Chris<br />

Aldous, Essilor NZ territory manager, adding<br />

Jaakko Suhonen, who previously worked for Essilor<br />

Finland as a specialist rimless fitter.<br />

“Finally, we are looking to employ an additional<br />

territory manager to enable closer contact<br />

with our customers around the country. We are<br />

working with our customers and industry figures<br />

to attract the best candidates for this new role,”<br />

said Aldous.<br />

“Adding to the expertise and strength of our<br />

current support team ensures we can deliver on<br />

the new planned service projects as well as new<br />

product launches planned for <strong>2018</strong>. All in all, we<br />

are looking forward to growing our support to<br />

independent practices in meeting their goals.” ▀<br />

ENROL NOW…<br />

OptomEdge<br />

signs Jayex<br />

Health tech company Jayex Healthcare has signed an<br />

exclusive worldwide ‘Solution Provider Agreement’ with<br />

OptomEdge, the optometry division of the Queenslandbased<br />

marketing and technology services provider, Valued<br />

Patient Group,<br />

and preferred<br />

online marketing<br />

support supplier<br />

for Kiwi-based<br />

independent<br />

optometry<br />

network Eyepro.<br />

Both<br />

Australian-based<br />

companies have<br />

identified a<br />

strong need for<br />

practice-focused<br />

communication<br />

technology in<br />

conjunction<br />

with effective<br />

marketing<br />

campaigns, said the companies in a joint statement.<br />

The agreement focuses on Jayex’s Appointuit online<br />

appointment booking service and its integrated SMS and email<br />

communication platform. “Optometry practices will now be able<br />

to benefit from pre-populated email newsletter content, which<br />

saves significant time and ensures that practices have a reliable<br />

way to keep in touch with patients between visits,” said the<br />

companies. “The collaboration between Jayex and OptomEdge<br />

is designed to give patients greater access to quality healthcare<br />

content and for practices to achieve greater efficiencies in<br />

converting awareness into appointments by delivering a patient<br />

experience which can be tailored to each practice.”<br />

“Appointuit’s platform of customisable appointment booking<br />

widgets and email newsletter deployment is better than<br />

anything else than we’ve seen on the market, which allows<br />

practices to maintain their branding and overall patient<br />

experience,” added Robert Springer, OptomEdge’s technical<br />

director. “The addition of real-time online appointments to our<br />

services portfolio allows us to achieve full ROI-tracking across<br />

marketing programmes to show practices exactly where to focus<br />

to achieve their goals.” ▀<br />

…and become a fully-accredited and trained<br />

Dispensing Optician in New Zealand<br />

HLT47815 – Certificate IV<br />

in Optical Dispensing is now<br />

open for <strong>2018</strong> enrolments.<br />

Workshop conveniently located<br />

in Glenfield, Auckland<br />

The expanded and expanding Essilor NZ team<br />

Enquiries and Enrolments www.acod.edu.au<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

21


MORE CLASSIFIEDS ON PAGE 24<br />

NZ SALES<br />

AGENT<br />

Optique Line NZ is seeking an enthusiastic, self-motivated sales<br />

agent to service our existing client base as well as seeking new<br />

opportunities to grow our market share in New Zealand.<br />

Our longstanding agent is retiring from the industry in a full-time<br />

capacity, so this presents a unique opportunity to continue the<br />

company legacy already established.<br />

Industry experience is required, whether as a sales representative,<br />

or from a dispensing background. Our preference is to be based on<br />

the North Island.<br />

Our extensive portfolio of brands includes Stepper Eyewear and<br />

Convertibles, which are well respected and established in the New<br />

Zealand market.<br />

We support our brands with marketing, as well as a first class<br />

customer service team.<br />

Generous commissions payable.<br />

If you wish to be part of a progressive company, please forward<br />

your CV to employment@optiqueline.com.au<br />

SNOWVISION<br />

CHARITABLE TRUST<br />

<strong>2018</strong> SCHOLARSHIPS<br />

The Trustees of the Snowvision Charitable Trust announce<br />

the offer of two scholarships – one for a New Zealand<br />

optometrist and one for a final year student completing<br />

the BOptom – to undertake a period of four weeks<br />

clinical study at the State College of Optometry, State<br />

University of New York (SUNY), New York. The successful<br />

applicants will be expected to spend a minimum of 40<br />

hours per week in the Optometry Department pursuing<br />

clinical studies as approved by the Trustees.<br />

The scholarship is for a maximum of NZ$7,000 and covers one<br />

return advance purchase economy airfare from Auckland to<br />

New York and the tuition fees at SUNY. Assistance in finding<br />

accommodation will be given if needed.<br />

The conditions of the scholarship include:<br />

The optometrist must be in full-time practice in New<br />

Zealand and must practise optometry full-time in New<br />

Zealand for two years following their return from SUNY.<br />

The student must practise optometry in New Zealand<br />

for two years at the completion of their degree.<br />

The holders must provide a written report of their time at<br />

SUNY to the Trustees within two months of their return.<br />

The holders must be prepared to give a brief (five<br />

minute) report to the Snowvision Down Under<br />

conference in August, 2020 in Queenstown.<br />

The holders must agree to their report, either in whole<br />

or in part, being published in NZ Optics magazine and<br />

elsewhere at the discretion of the Trustees.<br />

Requests for application forms should be sent to:<br />

Snowvision Charitable Trust<br />

PO Box 222, Mosgiel<br />

Email: hcaithness@xtra.co.nz<br />

Applications will close on May 31, <strong>2018</strong>. The decision of<br />

the Trustees will be final and in the event of there being<br />

no satisfactory applicant, no scholarship will be awarded.<br />

Hamish Caithness<br />

Trustee<br />

David Robinson<br />

Trustee<br />

To advertise in NZ Optics’<br />

classified pages contact:<br />

Susanne Bradley at susanne@nzoptics.co.nz<br />

You can see my house from here<br />

I hate heights. Briefly, as a young man, I had no fear of them. I<br />

would happily get onto the roof, trailing cable from my valve radio<br />

and attach it to the TV aerial so I could pick up Radio Hauraki from<br />

Feilding in the daytime. The TV went out just as Dad was settling<br />

in after a hard day’s farming to watch the cricket. The screen<br />

just went dead. There might have been smoke. There would be<br />

no TV for anyone until the repairman came. The teenage me<br />

slipped outside, swiftly retrieved the cable and skulked off to my<br />

room to resume brooding about the terrible world full of terrible<br />

people.<br />

By the time I was 25, I had escaped death in cars, on motorbikes,<br />

on mountains and in most of Wellington’s public bars. My brain<br />

was as fully formed as it was ever going to get and I was no longer<br />

so bold; more conscious of what you could do to your neck if you<br />

came off a roof.<br />

So here I am, decades later, spending the best days of this<br />

magnificent summer painting our high roof and, whenever I stop to<br />

reflect on what I’m doing, hating it. I am doing this because it very<br />

much needs to be painted and the days when you could just get<br />

some brave young guy to whip up there and get it done are gone.<br />

This is a good thing, I have to concede. Those looser days are gone.<br />

Even though those high-living guys are naturals up there, modern<br />

safety practices are there for those moments when a natural loses<br />

his footing. You can’t say those moments don’t happen.<br />

Last time, last house, I found a painter in the classifieds. His<br />

name was Hussein. He was from Iraq, and you never met a more<br />

obliging guy. Sure, he could do it, he said, like it was the simplest<br />

thing in the world. Up he went, all over the roof, quick and agile as<br />

a monkey.<br />

Once he got started, I realised that although he knew his way<br />

around a roof, his experience possibly came more from evading<br />

snipers than rolling on semi-gloss. But he was at home up there,<br />

and that made him the guy for the job. I went down to my office<br />

and he set about his work. In bare feet.<br />

Everything was good for a couple of hours but then grey clouds<br />

begin to roll over and soon it was spitting a little. Under his bare<br />

feet, the old finish on the roof had deteriorated and had a dusty<br />

surface. Dots of rain began to fall making the surface even harder<br />

to work on.<br />

“No trouble,” he said, “I keep working.” A few minutes later,<br />

I heard one hell of a crash. Hussein had come off the roof.<br />

Fortunately, there was a garden. Nothing broken, but he was<br />

thoroughly shaken. He went off to the doctor who said it was just<br />

bad bruising and he’d be fine, but he strongly recommended the<br />

patient stay off roofs. I thought to myself: that went a lot better<br />

than it might have.<br />

As much as I admire the high-wire skills of those guys, I don’t doubt<br />

Chalkeyes presents…<br />

Slack Times<br />

By David Slack*<br />

VSP partners Right Eye<br />

Large, US-based optics, eye health<br />

and eyewear group, VSP Global has<br />

partnered with eye-tracking technology<br />

firm Right Eye to expand new vision testing<br />

solutions for optometry.<br />

Announcing the investment last year,<br />

the companies said the partnership will<br />

explore the expansion of cutting-edge vision<br />

care solutions designed to strengthen the<br />

relationship between patients and their<br />

practitioners.<br />

Right Eye is a health technology company<br />

that uses eye tracking and gaming as<br />

innovative vision tests for assessing eye<br />

sight, concussion and other brain and head<br />

injuries and reading and learning disorders.<br />

The game-based vision tests require users to<br />

sit and follow graphics on a screen and range<br />

from tracking a dot around or identifying<br />

and blowing up aliens invading the Earth.<br />

Right Eye claims the resulting report,<br />

generated within minutes of a patient<br />

finishing a test, gives optometrists an<br />

objective, measurable way to view the quality<br />

OPSM’s 100 new grads<br />

Luxottica’s OPSM and Australian-based sister company Laubman<br />

& Pank have employed 100 optometry graduates to fill positions<br />

across Australia and New Zealand, doubling the number<br />

employed in 2017.<br />

Peter Murphy, Luxottica’s director of eyecare and community, said the<br />

increased intake was in response to greater demand from stores across<br />

Australia and New Zealand. “OPSM (provides) optometry services early<br />

mornings, weekends and evenings on late shopping nights, which has<br />

resulted in an increase need for optometrists.”<br />

“We offer graduates internal mobility to experience different working<br />

environments. Those who accept placements in a regional or remote<br />

area for six months or more are guaranteed a position back in their<br />

home city at the end of the tenure if that’s what they want to do. This<br />

has made them more receptive to moving.”<br />

Luxottica’s <strong>2018</strong> graduate optometrists were introduced to the<br />

company and each other at a celebratory Sydney harbour cruise in<br />

January. ▀<br />

that workplaces need to be<br />

safe. I also admire our<br />

ACC system that takes<br />

care of your personal<br />

injury by accident without<br />

asking who was to blame<br />

and tying everyone up in court<br />

for years. I also like that we have evolved a<br />

system, as we surely needed, to ensure that<br />

with ACC removing the jeopardy of your<br />

being sued for being unsafe, we have a<br />

system that ensures workplaces are safe.<br />

There is no more damning indictment of<br />

the consequences of putting revenue and<br />

profits above safety than the story told in Rebecca Macfie’s account<br />

of the Pike River disaster, Tragedy at Pike River Mine.<br />

But here I stand on kitset scaffolding I bought from Trademe in<br />

order to get myself up high enough to paint the house myself. I<br />

don’t especially like it, but it’s not safe or right to ask someone to<br />

do it without proper protection. But – and at last we arrive at my<br />

point – have you seen the cost of getting your house bundled up in<br />

scaffolding these days? Have you heard how long you have to wait<br />

for it?<br />

A market that doesn’t seem to be functioning the way they<br />

taught us it would in high school economics has driven me up a<br />

wobbling metal tower. You talk about this and you hear a repeating<br />

complaint: I have to paint my house, but you can’t get a ladder up<br />

there, and have you seen the cost of scaffolding these days?<br />

What this means, at least for now, is that a decent chunk of<br />

Auckland’s property stock is not getting the maintenance it needs.<br />

Heaven only knows what will happen if those buildings begin to leak.<br />

For a more serious look at today’s Health<br />

and Safety requirements, see Focus on<br />

Business on p14.<br />

*David Slack is an author, radio and TV commentator<br />

and speechwriter. He established the website speeches.<br />

com, and has published several books including<br />

‘Bullshit, Backlash and Bleeding Hearts’, exploring<br />

Treaty of Waitangi issues, and ‘Bullrush’, a social<br />

history of the popular children’s game.<br />

of a patient’s visual speed and accuracy, visual<br />

processing, depth perception, dry eye and<br />

more. The software can also track the success<br />

of remedies such as vision therapy, said Jon<br />

Schuller, senior public relations specialist at<br />

VSP Global.<br />

“VSP Global supports technological<br />

advancements that increase the value and<br />

utilisation of vision benefits, extends access<br />

and strengthens the tie between a patient<br />

and their optometrist… to help deliver a<br />

more enhanced patient experience.” ▀<br />

Some of the <strong>2018</strong> OPSM new Australasian graduate intake on the introductory<br />

Sydney Harbour cruise<br />

22 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong>


PUT DOWN YOUR<br />

ROOTS IN REGIONAL NZ<br />

PERMANENT ROLES IN YOUR CHOICE OF REGIONAL LOCATION<br />

Multiple opportunities available across both the North and South Islands to suit your career aspirations<br />

Specsavers’ growing New Zealand store network offers a variety of roles catering<br />

to different development needs and are available for optometrists at all stages of<br />

their career.<br />

Joining one of our regional New Zealand stores provides an ideal opportunity to<br />

firmly establish yourself within a community while progressing your clinical skills.<br />

You will be equipped with the latest ophthalmic equipment and presented with<br />

a range of interesting conditions across a high-volume patient base – all with the<br />

support of an experienced dispensing and pre-testing team, the mentorship of the<br />

store partners, and access to an exemplary professional development program.<br />

Or if you’re ready to move into practice ownership, our regional New Zealand stores<br />

present an attractive business venture. With average annual sales running at $2.4<br />

million per store, and Support Office training and assistance available every step of<br />

the way, there’s no better time to uncover the leader within you.<br />

Ask us about the opportunities we have waiting for you – contact Chris Rickard<br />

on 027 579 5499 or via chris.rickard@specsavers.com<br />

VIEW ALL THE OPPORTUNITIES AVAILABLE ON SPECTRUM-ANZ.COM<br />

Voted by New Zealanders<br />

Reader’s Digest<br />

Quality Service<br />

Award<br />

2017<br />

Best Talent<br />

Development<br />

Program<br />

2017<br />

Best Customer<br />

Service in NZ<br />

Optometry<br />

2017<br />

Millward Brown<br />

Research<br />

No.1 for eye tests<br />

2016<br />

Excellence in<br />

Marketing<br />

Award<br />

2016<br />

Retail<br />

Store Design<br />

Award<br />

2016<br />

Retail<br />

Employer<br />

of the Year<br />

2015<br />

Overall<br />

National<br />

Supreme Winner<br />

2015<br />

Franchise<br />

Innovation<br />

Award<br />

2015<br />

NZ Franchise<br />

System of<br />

the Year<br />

2014<br />

Retail<br />

Innovator<br />

of the Year<br />

2014<br />

<strong>March</strong> <strong>2018</strong><br />

NEW ZEALAND OPTICS<br />

23


MORE CLASSIFIEDS ON PAGE 22<br />

OPTOMETRIST WANTED<br />

We have an opportunity for a<br />

therapeutically qualified optometrist to<br />

become part of the Total Eyecare group.<br />

You need to be competent in full-scope optometry as our private<br />

practices embrace all aspects of clinical work, including diabetic<br />

retinal screening. An interest in customised rigid contact lens<br />

fitting would be an advantage. The practices are well equipped<br />

with anterior and posterior cameras, topography, automated Zeiss<br />

visual fields and Cirrus HD-OCT.<br />

You’ll have the support of an experienced team and opportunities<br />

for professional development.<br />

We are looking for someone who is motivated, with a good sense<br />

of humour and works well as part of a team. Enjoy the cafes,<br />

culture and and sporting events that the Wellington region<br />

uniquely offers.<br />

Please send your CV to greg@totaleyecare.co.nz<br />

All enquiries will be treated in confidence.<br />

BAILEY NELSON ALBANY<br />

Here at Bailey Nelson, we see things a little<br />

differently. We believe eye care doesn’t have to<br />

be boring, and that’s why it’s our mission to have passionate and<br />

caring Optometrists who ensure all patients enjoy an experience<br />

worth remembering. Our eye tests are tailored for each individual<br />

so everyone walks away feeling and looking different.<br />

Bailey Nelson is opening a new store in Albany, Auckland.<br />

If you want to further yourself as a leader and business contributor,<br />

all while delivering amazing eye care then get in touch.<br />

https://baileynelson.co.nz/pages/careers<br />

OPTOMETRIST<br />

REQUIRED<br />

Optik Eyecare Pukekohe is looking for a TPA qualified optometrist<br />

to join our team on a nine month fixed contract to cover maternity<br />

leave.<br />

We are an independent optometry practice in Pukekohe, South<br />

Auckland providing excellent eye care in our purpose built<br />

building.Our practice is clinically orientated, with a strong support<br />

team, and has excellent technology, including an OCT.<br />

You will be part of an Optometrist team of three. It’s a full-time<br />

position but part-time could be considered for the right applicant.<br />

We expect this contract to start mid June <strong>2018</strong>.<br />

In the first instance please forward your CV to Laurraine at<br />

admin@optik.co.nz<br />

For all your optical and ophthalmic needs<br />

nzowa.org.nz<br />

OPTOMETRIST<br />

NEW PLYMOUTH<br />

We are looking for an experience TPA qualified, full-time<br />

Optometrist to join our team at Browning & (Matthews), New<br />

Plymouth. This is a busy, well equipped practice with a great<br />

support team.<br />

Please contact Michelle Diez on 027 246 7499 or email<br />

michelle.diez@matthews.co.nz<br />

OPTOMETRY PRACTICE MANAGER<br />

An excellent opportunity has arisen for a Practice Manager<br />

responsible for three independent practices in Wanganui. You<br />

will be a valued member of a company providing a professional<br />

optometry service covering the full-range of specialist eye care<br />

and eyewear to accommodate all budgets, selected to suit each of<br />

the three practices’ patient base.<br />

The position offers fantastic long-term career prospects, personal<br />

development and training opportunities. Our client offers a<br />

perfect, pressure-free, working environment and atmosphere<br />

coupled with the opportunity to work alongside experienced<br />

optical professionals.<br />

The core values of this business are to deliver an outstanding<br />

personalised experience, guarantee excellence in all they do and<br />

make sure this is delivered by people with extraordinary team spirit.<br />

Working hours 8am-5.30pm Monday to Friday and occasional<br />

weekends (closed Sundays and Bank Holidays).<br />

Testing time 30 – 45 minutes.<br />

Key Benefits<br />

• Very competitive salary<br />

• Great work life balance (closed Sundays and Bank Holidays)<br />

• Clinical practices providing specialist services; specialist contact<br />

lenses, dry eye, low vision, direct cataract and paediatric referrals<br />

• Highly-established clientele creating a less sales driven and<br />

pressure free environment<br />

• Good staff rapport generates a very social working atmosphere<br />

• Excellent long term career prospects<br />

• Four weeks annual plus bank holidays<br />

To talk to us in confidence about this opportunity, please contact<br />

Stuart Allan at OpticsNZ on (03) 5466 996, 027 436 9091 or<br />

stu@opticsnz.co.nz<br />

Applications (CV and cover letter) for this position are invited (via<br />

the above email or via post, PO Box 1300, Nelson) prior to 5pm<br />

Monday 19 <strong>March</strong> <strong>2018</strong>.<br />

DREAM OF<br />

TRAVELLING<br />

Have you ever wanted to travel NZ? Do you like<br />

flexibility and crave variety? OPSM New Zealand is<br />

looking to expand its relief team with a combination<br />

of area and regional floats. As a float you will be<br />

exposed to lots of different patients and locations<br />

across New Zealand. We are looking for Optometrists<br />

who share our passion, and want to join our customer<br />

focussed teams in making a difference to how people<br />

see the world.<br />

We are looking for optometry floats in these<br />

key locations:<br />

• GREATER WELLINGTON AREA<br />

• AUCKLAND & WAIKATO AREA<br />

• NATIONAL (NZ WIDE) REGION<br />

Alternatively OPSM NZ is also on the lookout for locums<br />

willing to service the Wellington, Bay of Plenty and<br />

Waikato regions.<br />

JOIN OUR TEAM<br />

If interested in joining our fun loving team, please contact<br />

Jonathan Payne<br />

Jonathan.Payne@opsm.co.nz or call 021 195 3549<br />

OPSM.CO.NZ/CAREERS<br />

READY FOR<br />

A CHANGE?<br />

When you join OPSM, you work within a team who are<br />

committed to providing the best possible eyecare solution<br />

with exceptional customer service. You will work with world<br />

class technology and have many opportunities for professional<br />

development. You can also make a real difference in the<br />

way people see the world by participating in our OneSight<br />

outreach program. OPSM New Zealand is looking for<br />

passionate Optometrists to join the team in these locations:<br />

THAMES<br />

Located on the doorstep of the Coromandel, Thames is<br />

a gateway to outdoor adventures and fantastic beaches.<br />

An opportunity has arisen for a full time optometrist to<br />

join an amazing team in our community based store with<br />

interesting and appreciative clientele. Only 1 hour outside<br />

of South Auckland, Thames is close enough to enjoy the<br />

big city, without the traffic or house prices!<br />

MT MAUNGANUI<br />

Why visit this holiday hot spot when you can live there!<br />

Our brand new Mt Maunganui store is looking for a fresh<br />

optometrist eager to grow with the store. Located only 800<br />

meters from the beach, with relaxed easy going clientele.<br />

If you are seeking for a great mix of work and play,<br />

whether its surfing or just relaxing at the beach –<br />

“The Mount” is the ultimate summer destination.<br />

LOWER HUTT<br />

A rare vacancy has arisen in our much sort after Lower<br />

Hutt practice. We are currently looking to expand our<br />

energetic and vibrant team. Only 15 minutes from the<br />

capital, Lower Hutt is close enough to enjoy the sport,<br />

culture and cuisine that central Wellington has to offer.<br />

JOIN OUR TEAM<br />

If you are interested to find out more about joining the<br />

team, contact Jonathan Payne for a confidential chat.<br />

jonathan.payne@opsm.co.nz or call 021 195 3549<br />

OPSM.CO.NZ/CAREERS<br />

Thinking of selling your practice - we have buyers<br />

Considering buying - we’ll give you all the options<br />

OpticsNZ specialises in optometry practice sales,<br />

we've helped dozens of Optometrists buy and sell their practices<br />

For more information contact Stuart Allan on: 03 546 6996<br />

027 436 9091 stu@opticsnz.co.nz www.opticsnz.co.nz<br />

• Locum Service<br />

• Recruitment Services<br />

• Practice Brokering<br />

• Business Consultants<br />

24 NEW ZEALAND OPTICS <strong>March</strong> <strong>2018</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!